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Abstract 
 
Accurate protein localization is crucial to generate and to maintain cellular 
organization. Achieving accuracy is challenging, as the molecular signals that 
dictate a protein’s destination are often promiscuous. The localization of tail-
anchored (TA) proteins, whose transmembrane domain resides at its extreme C-
terminus, presents major challenges to protein targeting machineries. This 
dissertation explores how TA capture and release are spatially and temporally 
regulated in the Guided Entry of Tail Anchored proteins (GET) pathway and how 
endoplasmic reticulum (ER) destined TAs are targeted with high fidelity. 
 A quantitative framework of the Get3 ATPase cycle reveals that ATP and 
GET pathway effector proteins specifically induce multiple conformational 
changes in Get3, which culminate in the ATPase activation that drives 
unidirectional targeting in the pathway. The Get4/5 TA loading complex locks 
Get3 in the ATP-bound state that is primed for TA protein capture, whereas the 
TA substrate induces tetramerization of Get3 and activates its ATPase reaction.  
Additional analyses define multiple physicochemical features that 
distinguish TA proteins destined to different organelles. The GET pathway 
selects for these features at distinct stages using mechanisms such as 
differential binding, induced fit, and kinetic proofreading after ATP hydrolysis by 
Get3. These results reveal new roles for the cochaperone Sgt2 in providing key 
selection filters, and provide a biological logic for the complex cascade of 
substrate relay events during post-translational membrane protein targeting.  
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Chapter 1 : Introduction 
 
How cells achieve and maintain a high level of internal organization in a 
dynamic and crowded inner environment is a fundamental question in biology.  
To maintain order within a cell, specific interactions between macromolecular 
complexes must be precisely controlled in space and time.  
One of the major organizational challenges for the cell is efficient and 
accurate protein localization. Proteins destined for lipid membranes present a 
special challenge.  When membrane proteins are synthesized by cytosolic 
ribosomes, their hydrophobic transmembrane domains (TMDs) must be shielded 
from the aqueous cytosol until their stable integration into their target 
membrane. If a membrane protein is not properly targeted, it is prone to 
irreversible aggregation that can result in mis-localization and proteostatic stress 
(Shao and Hegde, 2011).   
While numerous membrane-protein targeting pathways have been 
identified in prokaryotes and eukaryotes (Cross et al., 2009) they share three 
fundamental features.  (1) A molecularly encoded signal that determines cellular 
localization; (2) multi-state targeting machineries that recognize the signal and 
cycle between the cytosol and membrane; and  (3) robust spatial and temporal 
coordination of substrate binding and release cycles (Akopian et al., 2013b). 
One elegant way the cell prevents TMD aggregation during protein 
targeting is to use the co-translational signal recognition particle (SRP) pathway. 
Through a series of highly coordinated interactions with the SRP receptor (SR), 
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SRP recognizes an N-terminal hydrophobic signal sequence soon after it 
emerges from the ribosome and targets the nascent chain to the translocon at 
the endoplasmic reticulum (ER) membrane.  Once the ribosome is docked on 
the translocon, the hydrophobic TMDs are translated directly into the membrane 
(Shao and Hegde, 2011).  
Due to their topology, tail-anchored (TA) proteins, which contain a single 
TMD at their extreme C-terminus, are excluded from the SRP pathway and must 
be post-translationally targeted (Hegde and Keenan, 2011; Kutay et al., 1995).  
TAs comprise 3-5% of the membrane proteome (Hegde and Keenan, 2011)  and 
mediate diverse cellular processes including protein translocation, vesicular 
transport, and protein quality control (Claessen et al., 2010; Hegde and Keenan, 
2011). While TA proteins are found in nearly all eukaryotic membranes, they are 
post-translationally targeted to the ER, the mitochondrial outer membrane 
(OMM), and peroxisomes (Chen et al., 2014; Kutay et al., 1993). Regardless of 
target membrane, the C-terminal TMD is both necessary and sufficient to ensure 
the appropriate localization of TA proteins (Beilharz, 2003; Whitley et al., 1996).  
In the TRC40/GET (Guided Entry of Tail-anchored proteins) pathway, a 
complex protein interaction cascade delivers TA proteins to the ER (Hegde and 
Keenan, 2011; Schuldiner et al., 2008; Stefanovic and Hegde, 2007). TA proteins 
are initially captured by the chaperone Sgt2 in yeast (Chartron et al., 2011; 
Wang et al., 2010) or the BAG6 complex in mammalian cells (Mariappan et al., 
2010). The Get4/5 complex (or its mammalian homologue TRC35/Ubl4a), which 
binds both Sgt2 (or Bag6) and the Get3 ATPase (or its mammalian homologue 
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TRC40) (Jonikas et al., 2009; Schuldiner et al., 2008), then enables the loading 
of TA protein from Sgt2 onto Get3, the central dimeric ATPase in the pathway 
(Wang et al., 2010; 2011a). The Get3/TA complex then binds its receptor, the 
Get1/2 complex, on the ER membrane, upon which the TA protein is released 
from Get3 and inserted into the membrane (Mariappan et al., 2011; Schuldiner 
et al., 2008; Stefer et al., 2011). This dissertation aims to explore how TA 
substrate capture and release are spatially and temporally regulated in the GET 
pathway and how ER destined TA substrates are targeted with high fidelity. 
Studies of spatial and temporal regulation in the GET pathway initially 
focused on Get3 for two reasons: (i) Get3 is a TA associated protein that cycles 
between the cytosol and the ER membrane and has been shown to interact with 
Get1, Get2, and Get4/5 (ii) Determining when and where ATP hydrolysis occurs 
provides insights into why ATP is required for TA targeting and what drives 
unidirectionality in the system.    
An abundance of structural information highlights that the nucleotide 
state of Get3 leads to multiple conformations (Bozkurt et al., 2009; Hu et al., 
2009; Mateja et al., 2009; Suloway et al., 2009; Yamagata et al., 2010). These 
range from an open state in apo-Get3 in which the helical subdomains within the 
dimer are separated, to more closed conformations in AMP-PNP or ADP•AlF4–-
bound Get3 in which the helical domains form a contiguous hydrophobic groove 
later shown to mediate TA protein binding (Mateja et al., 2015).   
Biochemical and structural data also indicate that different GET pathway 
effector proteins have preferences for different nucleotide states of Get3 
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(Gristick et al., 2014; Kubota et al., 2012; Mariappan et al., 2011; Rome et al., 
2014; Stefer et al., 2011). Data from multiple groups suggest that Get4 
preferentially binds Get3 in an ATP-bound state, which is primed for substrate 
loading in the structure (Chartron et al., 2010; Gristick et al., 2014; Wang et al., 
2010; 2011b). In contrast, the Get1 cytosolic domain preferentially binds apo-, 
open Get3 strongly suggesting that Get1 promotes the release of nucleotide and 
TA proteins from Get3 at the end of the targeting cycle (Kubota et al., 2012; 
Mariappan et al., 2011; Stefer et al., 2011).  
Chapter 2 addresses many broad questions regarding how the Get3 
ATPase cycle drives the efficient delivery of TA proteins: (i) When, where and 
how do ATP binding and hydrolysis occur in the GET pathway? (ii) What is the 
full range of conformations that Get3 can sample and to what extent do 
nucleotides and GET pathway effector proteins select for, or interact with, these 
conformations? (iii) Why is such a complex cascade of interactions necessary? 
Why is Get3 unable to directly capture the TA substrate and how does the 
Get4/5 complex drive the transfer of TA proteins to Get3? (iv) While the 
predominant model for TA protein binding invokes a closed Get3 dimer (Mateja 
et al., 2009; 2015), there is also evidence for a tetrameric Get3 complex: 
recombinant Get3/TA complexes are predominantly tetramers in size exclusion 
chromatography, and several archaeal Get3 homologues form obligate 
tetramers (Bozkurt et al., 2009; Suloway et al., 2011). Whether and how dimeric 
and tetrameric Get3 functions in TA protein targeting remain unclear. 
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 As a result of establishing a quantitative framework for the ATPase cycle of 
Saccharomyces cerevisiae (Sc) Get3 we demonstrate that Get4/5 and the TA 
substrate actively regulate this cycle to ensure the precise timing of ATP 
hydrolysis. These results provide an explicit model for how Get3’s ATPase cycle 
is coupled to conformational changes that drive TA protein targeting. 
Chapter 3 addresses the molecular basis for substrate selection in the 
GET pathway. We address how a single C-terminal TMD provides sufficient 
molecular information to differentiate TA proteins destined to diverse organelles.  
While it has been established that the C-terminal TMD of a TA protein is 
sufficient for its association with both Sgt2 and Get3 (Wang et al., 2010), it is 
unclear how the GET pathway senses and selects for TAs destined to the ER. 
Previous work has noted that hydrophobicity of TMDs and basic residues at the 
extreme C-termini contribute to TA localization (Borgese et al., 2007; 2003; 
Rapaport, 2003).  Our results rigorously define two properties that allow 
targeting machineries to discriminate TA proteins destined to different 
organelles. The GET pathway senses these properties at distinct stages and 
uses a variety of selection mechanisms including differential binding, induced fit, 
and kinetic proofreading after ATP hydrolysis by Get3. These results also reveal 
new roles for the cochaperone Sgt2 in providing key selection filters, and define 
a biological logic for the complex cascade of substrate relay events during post-
translational membrane protein targeting.  
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Chapter 2 : Precise Timing of ATPase Activation Drives 
Targeting of Tail-anchored Proteins 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A version of this chapter was first published as: Rome, M.E.*, Rao, M.*, 
Clemons, W.M., and Shan, S. O. (2013). Precise timing of ATPase activation 
drives targeting of tail-anchored proteins. Proc. Natl. Acad. Sci. 110, 7666–7671 
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Abstract 
 
 The localization of tail-anchored (TA) proteins, whose transmembrane 
domain resides at the extreme C-terminus, presents major challenges to cellular 
protein targeting machineries. In eukaryotic cells, the highly conserved ATPase 
Get3 coordinates the delivery of TA proteins to the endoplasmic reticulum (ER). 
How Get3 uses its ATPase cycle to drive this fundamental process remains 
unclear. Here, we establish a quantitative framework for the Get3 ATPase cycle 
and show that ATP specifically induces multiple conformational changes in Get3 
that culminate in its ATPase activation through tetramerization. Further, 
upstream and downstream components actively regulate the Get3 ATPase cycle 
to ensure the precise timing of ATP hydrolysis in the pathway: the Get4/5 TA 
loading complex locks Get3 in the ATP-bound state and primes it for TA protein 
capture, whereas the TA substrate induces tetramerization of Get3 and activates 
its ATPase reaction 100-fold. Our results establish a precise model for how Get3 
harnesses the energy from ATP to drive the membrane localization of TA 
proteins, and provide new insights into how dimerization-activated nucleotide 
hydrolases regulate diverse cellular processes. 
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Introduction 
 
 Proper localization of membrane proteins is essential for the structure 
and function of all cells. Tail-anchored (TA) proteins, which contain a single 
transmembrane domain at their extreme C-terminus, comprise 3-5% of the 
membrane proteome (Hegde and Keenan, 2011) and mediate diverse cellular 
processes including protein translocation, vesicular transport, and protein 
quality control (Claessen et al., 2010; Hegde and Keenan, 2011). Due to their 
topology, TA proteins cannot engage co-translational protein targeting 
machineries, and instead must use post-translational mechanisms for efficient 
and accurate delivery to the target membrane (Hegde and Keenan, 2011; Kutay 
et al., 1995).  
In the GET (Guided Entry of Tail-anchored proteins) pathway, a complex protein 
interaction cascade delivers TA proteins to the endoplasmic reticulum (ER) 
(Claessen et al., 2010; Hegde and Keenan, 2011; Schuldiner et al., 2008; 
Stefanovic and Hegde, 2007). TA proteins are initially captured by the 
chaperone Sgt2 in yeast (Chartron et al., 2011; Wang et al., 2010) or the BAG6 
complex in mammalian cells (Mariappan et al., 2010). The Get4/5 complex (or its 
mammalian homologue TRC35/Ubl4a), which binds both Sgt2 (or Bag6) and the 
Get3 ATPase (or its mammalian homologue TRC40) (Jonikas et al., 2009; 
Schuldiner et al., 2008), then enables the loading of TA protein from Sgt2 onto 
Get3, the central ATPase in the pathway (Wang et al., 2010; 2011a). The 
Get3/TA complex then binds its receptor, the Get1/2 complex on the ER 
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membrane, upon which the TA protein is released from Get3 and inserted into 
the membrane (Mariappan et al., 2011; Schuldiner et al., 2008; Stefer et al., 
2011). TA protein insertion is an ATP-dependent process (Kutay et al., 1995) 
driven by Get3/TRC40, an obligate ATPase homodimer (Chartron et al., 2012b; 
Mateja et al., 2009; Schuldiner et al., 2008; Stefanovic and Hegde, 2007; 
Suloway et al., 2009). Twenty-one Get3 structures, solved in various nucleotide 
states, show that nucleotide occupancy in the Get3 ATPase domain allows 
adjustments at its dimer interface that are amplified into larger displacements of 
its helical domains. This leads to various structures, from open conformations in 
apo-Get3 in which the helical subdomains are separated, to more closed 
conformations in AMPPNP- or ADP•AlF4–-bound Get3 in which the helical 
domains form a contiguous hydrophobic groove proposed to mediate TA 
protein binding (Bozkurt et al., 2009; Hunter, 2009; Mateja et al., 2009; Suloway 
et al., 2009; Yamagata et al., 2010). Further, the Get1 cytosolic domain 
preferentially binds apo-, open Get3 (Kubota et al., 2012; Mariappan et al., 2011; 
Stefer et al., 2011), strongly suggesting that Get1 promotes the release of 
nucleotide and TA proteins from Get3 at the end of the targeting cycle. 
Despite rich structural information, many key questions remain regarding 
how the Get3 ATPase cycle drives the efficient delivery of TA proteins. First, 
when, where and how ATP binding and hydrolysis occur in the GET pathway 
has been unclear. Second, ADP-bound Get3 has been solved in both open and 
closed structures (Mateja et al., 2009; Yamagata et al., 2010), raising questions 
as to the specificity of Get3 in recognizing nucleotides and generating 
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nucleotide-driven conformational changes. Third, the nucleotide states of Get3 
required for interacting with Get4/5 or for Get4/5-mediated loading of TA 
proteins remain controversial (Chartron et al., 2010; Wang et al., 2010; 2011a). 
Most importantly, models based on a two-state open ⇔ closed transition are 
insufficient to explain the complex cascade of protein interactions that must be 
coordinated by Get3, which requires multiple functional states in this ATPase.   
The requirement for the Sgt2•Get4/5 complex in the GET pathway raises 
additional questions. Why is Get3 unable to directly capture the TA substrate? 
How does the Get4/5 complex drive the transfer of TA proteins to Get3? Thus 
far, Get4/5 appears to be nothing more than a scaffold that brings Sgt2 and 
Get3 into close proximity. Whether Get4/5 can actively facilitate TA protein 
capture by Get3 is unclear.  
Finally, while the predominant model for TA protein binding invokes a 
closed Get3 dimer (Mateja et al., 2009), there is also evidence for a tetrameric 
Get3 complex: recombinant Get3/TA complexes are predominantly tetramers in 
size exclusion chromatography, and several archaeal Get3 homologues form 
obligate tetramers (Bozkurt et al., 2009; Suloway et al., 2011). Whether and how 
a Get3 tetramer functions in TA protein targeting remain unclear. 
 To address these questions, here we establish a quantitative framework 
for the ATPase cycle of Saccharomyces cerevisiae (Sc) Get3. We demonstrate 
that Get4/5 and the TA protein substrate actively regulate this cycle to ensure 
the precise timing of ATP hydrolysis. These results provide an explicit model for 
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how Get3’s ATPase cycle is coupled to conformational changes that drive TA 
protein targeting. 
 
Results 
Cooperative ATP binding to Get3. We began by establishing a quantitative 
framework for the Get3 ATPase cycle (Fig. 2.1). To probe for nucleotide-driven 
conformational changes, we compared Get3’s activity under two conditions: (i) 
‘single-site’ conditions, in which Get3 is in 10–1000 fold excess over the 
nucleotide so that, statistically the majority of nucleotide-bound Get3 dimers 
have a single ATPase site occupied; and (ii) ‘multi-site’ conditions, in which the 
nucleotide is in excess over Get3 so that both ATPase sites are occupied. 
Nucleotide binding to Get3 is measured using both ATPase assays (Fig. 2.2A 
and Supporting Information (SI): Fig. S2.1A) and direct measurements based on 
changes in anisotropy of the fluorescent ATP analogue 2'-/3'-O-(N'-
methylanthraniloyl)-ATP (mantATP; Fig. 2.2B). Under single-site conditions, Get3 
binds ATP weakly and displays no discrimination between ATP and ADP (Fig. 
2.2A, B; Fig. 2.1 & SI: Table S2.1, K1 & K9). In contrast, under ‘multi-site’ 
conditions, Get3’s ATPase reaction exhibited a cooperative dependence on ATP 
concentration, giving a Hill co-efficient of 2 and a ~10-fold higher affinity for 
binding of the second ATP (Fig. 2.2C; Fig. 2.1 & SI: Table S2.1, K3).  
To test the specificity of this cooperative effect, we directly measured the 
rates of nucleotide binding to and release from Get3 using: (i) environmentally 
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sensitive changes in mantATP under single-site conditions (SI: Fig. S2.1B); and 
(ii) FRET between a native tryptophan in Get3 and mantATP under multi-site 
conditions (SI: Fig. S2.1C; (Mariappan et al., 2011)). These measurements show 
that ATP binds two-fold faster and dissociates three-fold more slowly under 
multi-site conditions (Fig. 2.2D and SI: Fig. S2.2, black; Fig. 2.1 & SI: Table S2.1, 
k1, k-1 vs. k3, k-3), providing independent support for cooperative ATP binding to 
Get3. This cooperativity is specific for ATP: compared to single-site conditions, 
the rate of mantADP binding was unchanged, and ADP release is over three-fold 
faster under multi-site conditions (Fig. 2.2D and SI: Fig. S2.2, gold; Fig. 2.1 & SI: 
Table S2.1, k8, k-8 vs. k9, k-9), indicating that Get3 disfavors ADP occupancy at 
both active sites. Together, these results show that ATP specifically induces 
rearrangements in Get3 that lead to stronger binding of the second ATP 
molecule (Fig. 2.1, steps 1 & 3), whereas ADP does not.  
 
Tetramerization of Get3 activates ATP hydrolysis and is required for TA 
protein targeting. Unexpectedly, the observed ATPase rate constant at 
saturating ATP concentrations, or kcat, rises with increasing Get3 concentration 
(Figs. 2.2C & 2.3A). This phenomenon was observed even in the presence of 
BSA, an effective surfactant and crowding reagent, suggesting that it is unlikely 
to be caused by enzyme loss or inactivation at low concentrations. Instead, this 
result suggests that an oligomerization process stimulates Get3’s ATPase 
activity.  Quantitatively, these data are most consistent with a model in which 
dimeric Get3 is in dynamic equilibrium (Kd = 3.5 ± 1.9 µM) with tetrameric Get3, 
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which hydrolyzes ATP faster than dimeric Get3 (Fig. 2.1, steps 5–7; SI: Eq 2.9). 
Analysis of the data based on this model yielded a kcat value for tetrameric Get3 
of 1.3 ± 0.4 min-1 (Fig. 2.1 and Table S2.1, k6), over 100-fold faster than dimeric 
Get3 (Fig. 2.3A and SI: Fig. S2.3A; Fig. 1 and Table S2.1, k4). This phenomenon 
has previously escaped detection, likely because it is abolished in less 
physiological solution conditions (SI: Fig. S2.3B), whereas our ATPase 
measurements used the same buffer as for protein targeting/translocation 
reactions (Alberts, 2008). The transient nature of tetrameric Get3 could also 
render it susceptible to dissociation during size exclusion chromatography 
(Kiekebusch et al., 2012). 
  In a structure of the Methanocaldococcus jannaschii (Mj) Get3 tetramer, 
helix 8 plays a key role in stabilizing the tetramer interface. Mutations of 
conserved hydrophobic residues in this helix, F192D, M193D and M196D, 
destabilize the tetramer (Suloway et al., 2011). To independently test whether 
tetramerization of ScGet3 is responsible for ATPase activation, we mutated 
homologous residues in ScGet3 (P199D/M200D, M200D/L201D; Fig. 2.3B). 
Given their location, these mutations are unlikely to affect the TA binding groove 
of the dimer, but would specifically disfavor the formation or conformation of the 
tetramer. These mutations reduced activated ATP hydrolysis at high Get3 
concentrations to almost the same extent as mutant ∆181-210, a negative 
control that lacks a large portion of the putative TA-binding groove (Fig. 2.3A, B) 
and completely abolishes TA protein capture and targeting (SI: Fig. S2.4D). In 
contrast, the kcat values at low Get3 concentrations, where it is primarily a dimer, 
 15 
were largely unchanged in these mutants (Fig. 2.3A). As additional controls, we 
mutated residues in the putative TA binding groove of Get3 in the dimer model 
(F190D or I193D; (Mateja et al., 2009)).  In contrast to the mutants designed to 
disrupt the tetramer, F190D and I193D exhibit over 10-fold higher ATPase 
activity and tetramerize more favorably than wildtype Get3 (SI: Fig. S2.3C and 
Table S2.3). These results provide independent evidence that formation of a 
Get3 tetramer is required for activated ATP hydrolysis.   
  If tetramerization of Get3 and its associated ATPase activation were 
important, it would also be manifested in the targeting reaction. To test this 
hypothesis, we quantitatively measured the targeting and translocation of a TA 
substrate, Sbh1p, to ER microsomes (SI: Fig. S2.4A). An NXT glycosylation site 
was engineered into the C-terminus of Sbh1p, whose glycosylation reports on 
successful translocation across the membrane. Both the translation lysate and 
ER microsomes were derived from a ∆get3 strain, so that Sbh1p targeting is 
dependent solely on exogenously added Get3. The efficiency of Sbh1p targeting 
and translocation exhibited a cooperative dependence on Get3 concentration 
with a Hill coefficient of 2 (Fig. 2.3C and SI: Fig. S2.4B), suggesting that efficient 
targeting requires two Get3 dimers to further associate to form a tetramer. 
Additionally, mutants P199D/M200D and M200D/L201D exhibit defects in 
targeting (Fig. 2.3D and SI: Fig. S2.4C) that quantitatively correlate with their 
defects in tetramerization-induced ATPase activation (Fig. 2.3D). Combined with 
previous observations that mutants M200D and L201D are deficient in TA 
substrate binding and supporting cell growth (Mateja et al., 2009), these results 
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provide strong evidence that transient formation of a Get3 tetramer is required 
for efficient TA protein targeting.  
 
Get4/5 enhances ATP binding but inhibits ATP hydrolysis by Get3. We next 
asked how the Get4/5 complex, which acts as a scaffold to facilitate TA protein 
loading from Sgt2 onto Get3, regulates the Get3 ATPase. Intriguingly, Get4/5 
stoichometrically inhibits the ATPase activity of Get3 (Fig. 2.4A & SI: Fig. S2.5A). 
Analysis of the ATP concentration dependence of the reaction showed that the 
average KM value is lowered to 1.4 ± 0.3 µM with Get4/5 present, indicating that 
Get3 binds ATP more strongly when it is bound to Get4/5 (Fig. 2.4B & SI: Fig. 
S2.5B). In contrast, Get4/5 reduced the value of kcat, indicating specific inhibition 
of ATP hydrolysis (Fig. 2.4B). Thus, Get4/5 induces Get3 into an alternative 
conformation in which ATP is bound more tightly but held in a catalytically 
compromised structure. 
 To provide independent evidence for this model, we tested how Get4/5 
alters nucleotide binding of Get3 using the FRET assay. Get4/5 did not affect 
the rate of ATP binding to Get3 (Fig. 2.4C) but reduced the rate of ATP 
dissociation from Get3 at least 10-fold (Fig. 2.4D), providing direct evidence that 
Get3 binds ATP more tightly when it is bound to Get4/5. This effect is specific 
for ATP, as under the same conditions ADP release from Get3 remained fast and 
was largely unaffected by Get4/5 (SI: Fig. S2.5C).   
If Get4/5 induces stronger ATP binding to Get3, then ATP-bound Get3 
would also bind more strongly to Get4/5. To test this prediction, we measured 
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complex formation between Get3 and Get4/5 using gel filtration 
chromatography. With apo-Get3, complex assembly was not detected even at 
micromolar protein concentrations (SI: Fig. S2.5D). In contrast, with saturating 
ATP present almost all Get3 formed a complex with Get4/5 (SI: Fig. S2.5E). 
These results, though qualitative, are consistent with previous pull-down 
experiments in which a stable Get3-4/5 complex was enriched in the presence 
of nucleotides (Chartron et al., 2010; Wang et al., 2010; 2011a) Together, these 
results show that Get4/5 preferentially binds ATP-loaded Get3 and reciprocally, 
interaction with Get4/5 enables ATP to be more tightly bound to Get3. 
As the Get3 ATPase activity is activated upon tetramerization, we asked 
whether Get4/5 inhibits this activation. Get4/5 also stoichiometrically inhibits the 
ATPase reaction at high Get3 concentrations, where it is predominantly a 
tetramer (SI: Fig. S2.5A). With saturating Get4/5 and ATP, the ATPase rate 
constant stayed constant at 0.16 ± 0.07 min-1 and was independent of Get3 
concentration (Fig. 2.4E). Thus, Get4/5 inhibits formation of the Get3 tetramer or 
the ATPase activation induced by tetramerization.  
Mutants F190D and I193D exhibit higher ATPase activities than wildtype 
Get3 in both the dimeric and tetrameric forms; both of these activities are 
substantially reduced in the presence of Get4/5 (Fig. 2.4F). Thus, these 
superactive mutant ATPases provide stronger evidence that the ATPase activity 
of dimeric Get3 is also inhibited by the Get4/5 complex. 
 
TA protein induces rapid ATP hydrolysis and locks Get3 in the ADP-bound 
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state. 
  We next asked how the TA protein substrate regulates the Gte3 ATPase. 
To this end, we co-expressed Get3 with Sbh1p. The Get3/Sbh1 complex 
purified predominantly as a tetrameric complex (SI: Fig. S2.6A), consistent with 
previous observations (Bozkurt et al., 2009; Suloway et al., 2011). 
 To determine the ATP hydrolysis rate from this complex, we carried out pre-
steady-state measurements using a high ATP concentration and Get3 active 
sites in 1:5 stoichiometry relative to ATP. Under these conditions, the ATPase 
reaction exhibited two distinct kinetic phases: (i) an initial burst whose 
magnitude increased with increasing Get3 concentration (Fig. 2.5A & SI: Fig. 
S2.6B), representing a rapid first round of ATP hydrolysis; and (ii) a slower linear 
phase representing subsequent rounds of ATP turnover at steady-state. The rate 
constant for the first round of ATP hydrolysis is 3.3 ± 1.1 min-1 (SI: Eq 2.10), over 
100-fold faster than that of the Get3 dimer. The rate constant for steady-state 
ATP turnover is 0.055 ± 0.001 min-1, 60-fold slower than the first turnover. Thus, 
loading of TA protein onto Get3 activates one round of ATP hydrolysis, but 
subsequent ATP turnover is inhibited. Further, ATPase activation in the Get3/TA 
complex was not observed under single-site conditions (Fig. 2.5B; cf. Fig. 2.2A), 
suggesting that it requires both Get3 active sites to be bound with ATP. Finally, 
the magnitude of the burst phase is stoichiometric with the concentration of 
Get3 active sites, suggesting that all four ATPs in the Get3 tetramer are 
hydrolyzed during the first turnover. 
 To test whether nucleotide binding or release could be rate-limiting for the 
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observed ATPase rates, we used the fluorescence assays to directly measure 
these events. MantATP binding to the Get3/Sbh1 complex was slow and 
concentration-independent at the lowest concentrations tested under both 
multi-site (Fig. 2.5C & SI: Fig. S2.6C) and single-site conditions (SI: Fig. S2.6D), 
suggesting that a slow conformational change of the Get3/Sbh1 complex 
becomes rate-limiting for ATP binding. The rate of the dominant, slow phase in 
ATP binding is similar to that of the burst phase in the ATPase reaction (5.0 vs. 
3.3 min-1), suggesting that the ATPase rate constant observed here may still be 
limited by a conformational change that precedes hydrolysis.  
 Remarkably, dissociation of ADP is at least 100-fold slower in the 
Get3/Sbh1 complex compared to free Get3 (Fig. 2.5D and SI: Table S2.2) and is 
indistinguishable from that of ATP or non-hydrolyzable ATP analogues (SI: Fig. 
S2.6E and Table S2.2), suggesting that the nucleotides are bound tightly and 
shielded from solvent in this complex. Nevertheless, ADP release from the 
Get3/TA complex is still 200-fold faster than the steady-state ATPase rate and is 
unaffected by up to 10 mM inorganic phosphate (SI: Fig. S2.6E and Table S2.2). 
This indicates that an additional conformational step, rather than product 
release, is rate-limiting for steady-state ATP turnover. Together, these data 
argue that only one round of ATP hydrolysis occurs in the GET pathway, after 
which the Get3/TA complex is locked in a catalytically inactive state loaded with 
ADP, and disassembly of this complex would be needed to reset its ATPase 
cycle. 
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Discussion 
 
Efficient and accurate delivery of membrane proteins often requires 
energy input from nucleotide triphosphates, which in the GET pathway is 
harnessed and utilized by the Get3 ATPase (Chartron et al., 2012b; Saraogi et 
al., 2011a). When, where, and how ATP binding and hydrolysis occur in the GET 
pathway remain open questions. Little is known about how Get3’s nucleotide 
state, conformation and activity are regulated during TA protein targeting. Here, 
quantitative mechanistic analyses define a precise framework for Get3’s ATPase 
cycle and elucidate how it is used to drive this fundamental cellular process. 
Previous work showed that Get3’s ATPase domain acts as a fulcrum at 
the dimer interface to generate a variety of structures (Chartron et al., 2012b). 
The cooperative ATP binding observed here supports a model in which Get3 
changes from a largely open conformation in apo-Get3 to increasingly closed 
conformations upon successive ATP binding (Fig. 2.1, steps 1 & 3). Importantly, 
this cooperativity is specific to ATP but not ADP. Thus, an ADP-bound Get3 
dimer remains in a largely open conformation (Suloway et al., 2009; Yamagata et 
al., 2010), despite the occasional observation of ‘closed’, ADP-bound Get3 
structures (Bozkurt et al., 2009). Nevertheless, the cooperativity induced by ATP 
is fairly modest, ~10-fold. Together with previous work (Wereszczynski and 
McCammon, 2012), we speculate that Get3 exists in an ensemble of 
conformations that are in close equilibrium with one another, and each ATP 
binding event induces a modest shift in the conformational landscape. Thus, 
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even the Get3 dimer bound with both ATPs is not completely ‘closed’, and is 
termed semi-closed here (Fig. 2.1).  
 Intriguingly, Get3 is catalytically activated through tetramerization (Fig. 
2.1, steps 5, 6). This phenomenon was previously suggested by the structure of 
an MjGet3 tetramer and by the formation of tetrameric Get3/TA complexes 
(Suloway et al., 2011). Our findings, for the first time, provide a function for 
tetrameric Get3, showing that it is the active species for ATP hydrolysis and for 
efficient TA protein targeting. In further support of this model, hydrophobic 
residues in helix 8 that stabilize the tetramer interface are conserved (Suloway et 
al., 2009; 2011); their mutations disrupt ATPase activation and protein targeting 
by Get3 (this work) and lead to defects in cell viability and TA binding (Mateja et 
al., 2009; Suloway et al., 2011). Given the location of these residues, these 
phenotypes are difficult to reconcile with a dimeric model for Get3. Although 
each of these observations can be explained by alternative models, activation of 
Get3 via tetramerization provides a cohesive, unifying model that explains this 
diverse collection of data.   
In vivo, tetramerization of Get3 by itself should be disfavored to minimize 
futile ATPase cycles. This could be achieved in part by the low in vivo 
concentration of Get3, ~1 μM (Ghaemmaghami et al., 2003), which is below the 
Kd value for tetramerization (3.5 μM). The results here further show that futile 
ATPase cycles of Get3 are minimized by the Get4/5 complex, which mediates 
the loading of TA proteins from Sgt2 onto Get3 (Wang et al., 2010; 2011a). 
Despite previous reports of Get4/5 binding to apo-Get3 (Chang et al., 2012), our 
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results demonstrate that Get4/5 preferentially binds ATP-loaded Get3 and locks 
it in the ATP-bound state (Fig. 2.6, step 2). This is achieved by tightening Get3’s 
ATP binding but inhibiting its hydrolytic activity, particularly the tetramerization-
induced activation of ATP hydrolysis. Get4/5 could exert these effects by 
inducing Get3 into a distinct, ‘occluded’ conformation in which its ATPase site is 
more closed but incompetent for hydrolysis (Fig. 2.1). In addition, Get4/5 could 
prevent Get3’s tetramerization. The latter model is particularly attractive as it 
explains why Get5 is a stable dimer (Chartron et al., 2012a): a complete Get4/5 
complex could hold two closed Get3 dimers in the ATP-bound state, priming 
them for subsequent tetramer formation once the TA protein is loaded onto Get3 
(Fig. 2.6, step 3). Regardless of the model, our data show that Get4/5 is not a 
passive scaffold that simply brings Sgt2 and Get3 into close proximity. Rather, 
Get4/5 actively promotes TA protein loading onto Get3 by locking it in the 
correct nucleotide state and priming its conformation for TA substrate capture 
(Mariappan et al., 2010; Wang et al., 2010). 
In contrast to Get4/5, multiple evidence strongly suggest that the TA 
protein induces the tetramerization and activation of Get3’s ATPase activity (Fig. 
2.6, step 3): (i) co-expression of TA protein with Get3 results in a stable Get3 
tetramer (this work; (Bozkurt et al., 2009; Suloway et al., 2011)); (ii) Rapid ATP 
hydrolysis was observed with the Get3/TA complex, as would be expected for 
an activated Get3 tetramer. Several important lessons are learned from analysis 
of the Get3/TA complex. First, after the first round of ATP hydrolysis, 
subsequent ATP turnover is 60-fold slower and incompatible with the timescale 
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of protein targeting in vivo, arguing that only one round of ATP hydrolysis occurs 
in the GET pathway. Second, following ATP hydrolysis, Get3 is locked in a 
catalytically inactive state. Together with observations with the Get3•Get4/5 
complex, these results demonstrate that the open-to-closed rearrangement of 
Get3 can be conceptually and experimentally uncoupled: even when Get3 is 
globally ‘closed’ and nucleotide release is slow, additional active site 
adjustments specifically regulate catalytic activity. We speculate that this relates 
to local rearrangements of the switch II loops (Chartron et al., 2012b), which 
provide multiple essential catalytic residues. The ADP-bound MjGet3 tetramer 
structure possibly provides a view of a closed but catalytically inactive Get3 
tetramer, in which the switch II loop is pulled away and incompatible for 
hydrolysis (Suloway et al., 2011). Finally, ADP release is substantially slowed in 
the Get3/TA complex and becomes indistinguishable from that of ATP, 
suggesting that the TA protein is dominant in inducing a closed Get3 tetramer.  
In the context of the targeting cycle, TA-induced Get3 tetramer formation 
would be beneficial as the hydrophobic TM of the TA substrate can be 
completely protected in a cage at the tetrameric interface (Suloway et al., 2011), 
minimizing its potential aggregation (Fig. 2.6). Our results also suggest that 
following hydrolysis, ADP release from the Get3/TA complex may be delayed 
until Get3 finds the Get1/2 membrane receptor. Tetramer disassembly by this 
receptor would be needed to release the TA protein. As ATP- and Get1-binding 
to Get3 are strongly antagonistic to one another (Mariappan et al., 2011; Stefer 
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et al., 2011; Wang et al., 2011a), ATP hydrolysis in the Get3/TA complex likely 
primes it for disassembly at the membrane.  
Collectively, our results lead to a new model for how the Get3 ATPase 
cycle is used to drive TA protein targeting (Fig. 2.6). Under cellular conditions, 
the majority of Get3 cooperatively binds ATP at both active sites, which induces 
it into a semi-closed conformation (step 1). ATP-loaded Get3 is preferentially 
captured by Get4/5, which brings Get3 into the vicinity of Sgt2 and induces the 
Get3 dimer into an ‘occluded’ conformation in which it is further closed but ATP 
hydrolysis is delayed (step 2). In this configuration, Get3 is primed to capture the 
TA substrate from Sgt2 (step 2). Loading of TA protein induces tetramerization 
of Get3 (step 3), which might also drive dissociation of Get3 from Get4/5. The 
tetrameric Get3/TA complex undergoes a rapid round of ATP hydrolysis, giving 
a stable ADP-loaded complex that binds its receptor, Get1/2, at the ER 
membrane (step 4). Tetramer disassembly, ADP dissociation, and TA protein 
release into the membrane are likely coupled, resulting in Get1 bound to apo-
Get3 in the open conformation (step 5). ATP binding then releases Get3 from 
Get1 (Mariappan et al., 2011; Stefer et al., 2011; Wang et al., 2011a) to re-initiate 
the cycle.   
 Get3 is the only eukaryotic ATPase in the SIMIBI (for SRP, MinD, and 
BioD) family of deviant P-loop NTPases, including the SRP and SRP receptor 
(SR) that mediate co-translational protein targeting (Leipe et al., 2002). Although 
the details of each system differ, the results here reveal many similarities in the 
regulatory principles between Get3 and SRP/SR. Both exhibit low nucleotide 
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affinity and forego the need of external exchange factors and activating proteins 
as regulatory elements (Shan et al., 2009). Instead, both use dimeric complexes 
as the functional unit. As dimers, both undergo conformational changes on the 
global (open → closed transitions) and local (catalytic loop adjustments) scale to 
generate multiple functional states during an NTPase cycle. For both, these 
rearrangements provide key regulatory points to sense and respond to upstream 
and downstream components and effect the precise timing of nucleotide 
hydrolysis in the pathway: GTP hydrolysis in the SRP/SR complex is stalled by 
the translation ribosome and re-activated by the SecYEG machinery (Zhang et 
al., 2009) (Akopian et al., 2013a), whereas ATP hydrolysis in Get3 is stalled by 
Get4/5 and activated by the TA substrate. Based on regulatory principles, Get3 
could be placed in the class of NTPases regulated by dimerization (Gasper et 
al., 2009) whose members, aside from SRP and SR, also include the human 
GBP1, the septins, HypB, MnmE, and the dynamin family of GTPases (Chappie 
et al., 2010; Gasper et al., 2009). Investigation of Get3 undoubtedly enhances 
our understanding of the mechanism, regulation, and evolution of this novel 
class of regulators.  
 
Materials and Methods 
 
Protein expression and purification. Mutant Get3s were generated using 
Quikchange Mutagenesis protocol (Stratagene). Wildtype and mutant Get3s 
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were expressed and purified as described (Chartron et al., 2010; Suloway et al., 
2009). Purification of the Get4/5 and Get3/Sbh1 complexes is described in SI.  
 
Fluorescence measurements. All fluorescent nucleotides were from Jena 
Biosciences. All measurements were carried out at 25 °C in Get3 assay buffer 
(50mM HEPES pH 7.4, 150mM potassium acetate, 5mM magnesium acetate, 
1mM DTT and 10% glycerol) using a Fluorolog-3-22 spectrofluorometer (Jobin 
Yvon) or a Kintek stopped-flow apparatus.  Determination of individual rate and 
equilibrium constants is described in SI. 
 
  
ATPase assays. All reactions were performed in Get3 assay buffer at 25 °C with 
[γ-32P]-ATP (MP Biomedicals). Reactions at Get3 concentrations below 0.5 µM 
also included 0.2 mg/mL BSA. Reactions were quenched in 0.75 M potassium 
phosphate (pH 3.3), analyzed by PEI cellulose thin layer chromatography (TLC) 
in 1 M formic acid/ 0.5 M LiCl, and quantified by autoradiography. Observed 
rate constants were obtained as described (Peluso et al., 2001). Determination 
of individual rate and equilibrium constants is described in SI. 
TA protein targeting and translocation. Yeast translation extracts were 
prepared as described (Suloway et al., 2011; Wu et al., 2007), except that an 
additional centrifugation step (SW55Ti, 30 min at 49,000 rpm) was included prior 
to chromatography on the G25 column. Yeast microsomes were prepared as 
described (Rothblatt and Meyer, 1986; Schuldiner et al., 2008). Translation and 
translocation of TA protein is detailed in SI. 
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Supplementary Materials and Methods 
 
Protein expression and purification.  Get4/5 and the Get3/Sbh1 complexes 
were expressed and purified according to previously published protocols with 
slight modifications (Chartron et al., 2010; Suloway et al., 2011). For Get4/5, the 
tetrameric fractions from MonoQ and size-exclusion chromatography were 
collected and used for all assays. For Get3/Sbh1, N-terminally tagged MBP-
thrombin-Get3 and His6-tagged Sbh1 were purified by affinity chromatography 
using Ni-NTA, followed by the amylose resin (NEB). Proteins eluted from 
amylose resin were treated with thrombin overnight at room temperature. The 
resulting thrombin digest was separated by size exclusion chromatography 
(Superdex 200, GE Healthcare) and the tetrameric Get3/Sbh1 fractions were 
collected and pooled. All proteins were exchanged into Get3 assay buffer in the 
gel filtration step.   
Fluorescence measurements. 
Equilibrium nucleotide binding under single-site conditions. 
Measurements were based on a fluorescence anisotropy readout with identical 
numerical processing as described previously  (Zhang et al., 2010). Samples 
were excited at 355 nm and fluorescence emission at 448 nm was monitored. 
For all titrations, mantATP/ADP was held constant at 0.3 μM and Get3 was 
varied as indicated. Incubation time was calculated based on the nucleotide 
binding rate under the same conditions, and varied from 5 to 10 minutes 
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depending on Get3 concentration.  Observed anisotropy values (Aobsd) were 
plotted as a function of Get3 concentration and fit to Eq 2.1,  
Aobsd = A0 + (A1 − A0 )×
[Get3]
[Get3]+Kd
,   (2.1)   
in which A0 is the anisotropy value of free mantATP/ADP, A1 is the anisotropy 
when mant-ATP/ADP is bound to Get3, and Kd is the equilibrium dissociation 
constant of Get3 for mantATP/ADP. 
 Competition of ATP with mantATP.  To test whether the mant group 
perturbs the binding affinity of ATP to Get3, 1.5 μM Get3 and either 8 or 11 μM 
mantATP were pre-incubated for 10 minutes and titrated with ATP.  The 
observed fluorescence (Fobsd) were fit to Eq 2.2,  
   Fobsd = F0×
Ki,app
[ATP]+Ki,app
+F1 ×
[ATP]
[ATP]+Ki,app
,  (2.2) 
in which F0 is the fluorescence in the absence of the competitor, F1 is the 
fluorescence in the presence of saturating competitor, and Ki,app  is the apparent 
inhibition constant of ATP at the specified mantATP concentration, determined 
to be 14.2 μM at 8 μM mantATP and 18.5 μM at 11 μM mantATP.  These Ki,app  
values are related to the true inhibition constant of ATP, Ki, by Eq 2.3,  
   
Ki,app = Ki× (1+
[mantATP]
Kd
) ,    (2.3) 
in which Kd is the equilibrium dissociation constant of mantATP.  The value of Ki 
determined from these experiments is 4.6 ± 0.1 µM, the same, within error, as 
the Kd value determined for mantATP, indicating that the mant group does not 
perturb the binding of ATP to Get3. 
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 Nucleotide association and dissociation kinetics. All rate measurements 
were performed on a Kintek stopped-flow apparatus. Under single-site 
conditions, the environmental sensitivity of mantATP/ADP was used as a 
readout. Samples were excited at 355 nm and fluorescence emissions were 
collected at 445 nm. MantATP/ADP concentration was held constant at 0.3 μM 
and Get3 concentration was varied as indicated. Observed rate constants (kobsd) 
were plotted as a function of Get3 concentration and fit to Eq 2.4,  
kobsd = kon[Get3] + koff,   (2.4) 
in which kon is the association rate constant, and koff is the dissociation rate 
constant.  
 Under multi-site conditions, FRET between a native tryptophan in Get3 
and mantATP/ADP was used. Samples were excited at 280 nm and 
fluorescence emission was collected at 445 nm. For association rate 
measurements, Get3 was held constant at 1.5 μM and mant-ATP/ADP 
concentration was varied as indicated. The data were fit to Eq 2.4 above, except 
that the concentration of Get3 was replaced with that of mantATP/ADP. For 
dissociation rate measurements, a pulse-chase setup was used. A complex 
between Get3 and mantATP/ADP (at 30 μM) was preformed by incubation for 10 
minutes, followed by addition of unlabeled ATP•Mg2+ or ADP•Mg2+ at 2-4 mM as 
the chase to initiate mantATP/ADP dissociation. The time course for change in 
acceptor fluorescence (Fobsd) was fit to either a single (Eq. 2.5) or double (Eq. 2.6) 
exponential function, in which Fe is the fluorescence when reaction reaches 
equilibrium, DF1 and kfast are the magnitude and rate constant of the 
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fluorescence change in the fast phase, and DF2 and kslow are the magnitude and 
rate constant of the fluorescence change in the slow phase,  
Fobsd = Fe  + ΔF1 × e–kfastt    ,                                    (2.5) 
Fobsd = Fe  + ΔF1 × e–kfastt + ΔF2 × e–kslowt  .      (2.6) 
Eq 2.6 was often needed to fit kinetic data, because the time courses for 
mantATP/ADP binding or dissociation were biphasic in most cases (Figure 
S2.7). We cannot rule out the possibility of enzyme conformational changes or 
heterogeneity that might in part give rise to the biphasic behavior. Nevertheless, 
the following strongly suggests that this behavior is primarily caused by 
heterogeneity in the mant nucleotides (where the mant group isomerizes 
between the 2’- and 3’-position). (i) The relative magnitude of the two kinetic 
phases, in the absence of perturbation by enzyme, is ~35%:65%, comparable 
to the equilibrium distribution of the two isomers (Cremo et al., 1990). (ii) In 
single-site binding measurements, while the observed rate constants from the 
fast phase showed a linear concentration dependence expected for bi-
molecular association, the rate constants for the slow phase are concentration 
independent and occur at a time scale (kslow ~ 0.005 s-1) consistent with the time 
scale for conversion of one mant isomer to the other (Eccleston et al., 2006). (iii) 
The relative magnitudes of the two kinetic phases in binding measurements are 
unchanged by varying Get3 concentration, but the magnitude of the fast phase 
increases with increasing concentration of ATP or mantATP. This is inconsistent 
with enzyme heterogeneity giving rise to the biphasic behavior (as the faster 
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binding enzyme population would sequester most of the ATP and dominate the 
signal if this were the case). Instead, these observations are expected if the 
faster-binding mant-isomer sequesters most of the enzyme and dominates the 
signal at higher concentrations.  Further, unlabeled ATP also increases the 
magnitude of the fast phase, suggesting that the faster-binding isomer favors 
the same binding mode as that for ATP. For these reasons, and because the 
kinetics and equilibrium derived from the fast phase were in excellent agreement 
with those from direct ATPase assays, the faster-binding isomer faithfully 
reports on the nucleotide binding and release kinetics of Get3 and were used for 
determination of binding constants in this work (Figure 2.1 and Table S2.1).  
Although it is theoretically possible to remove one of the mant isomers by 
substituting 3’-OH with 3’-H, we found that this substitution itself significantly 
weakens nucleotide binding to Get3 and hence could not be used to obtain the 
correct rate and equilibrium constants.   
 
ATPase measurements. 
 Single-site, single turnover ATPase rate (k2). Get3 was in excess over a 
trace amount of ATP* (<0.1nM) and titrated at indicated concentrations.  The 
data were fit to Eq 2.7: 
    kobsd = kcat ×
[Get3]
[Get3]+KM
.   (2.7) 
Here, kcat is the rate constant at saturating Get3 concentration, and KM is the 
concentration of Get3 required to reach half saturation.  
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 Multi-site, multiple turnover Get3 ATP hydrolysis rate.  In this assay, a 
fixed amount of Get3 was titrated with excess ATP as indicated.   The data were 
fit to an allosteric sigmoidal curve with a Hill coefficient of two (Eq 2.8):  
    kobsd =
kcat ×[ATP]2
KM2 +[ATP]2
.     (2.8) 
Here, kcat is the rate constant at saturating Get3 concentrations, and KM2 is the 
product of ATP binding affinities for the first and second active site, i.e., 
KM2 = K1 ×K3 .  
 ATPase activation through tetramerization of Get3. Observed kcat values 
were determined under multi-site conditions as above, at a series of Get3 
concentrations. The plot of observed kcat as a function of Get3 concentration 
was fit to Eq 2.9,  
  observed  kcat = k6 + (k4 − k6 )×
−K5 + K52 + 4K5[Get3]( )
2[Get3] ,  (2.9) 
where k4, k6, and K5 are defined in Figure 2.1.   
 ATPase rate constants in the Get3/Sbh1 complex.  Pre-steady-state 
measurements were carried out with Get3 active sites in 1:2.5 – 1:10 
stoichiometry relative to saturating ATP (1 mM), so that both the first and 
subsequent ATP turnovers can be visualized.  The reaction time course is bi-
phasic, as explained in the text, and was fit to Eq 2.10, 
  Fraction(ATP) = (a− b)e–kburstt − klineart + b ,    (2.10) 
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where a is the fraction of ATP before initiation of the reaction, b is the reaction 
end point,  kburst is the rate constant associated with the burst phase and klinear is 
the rate associated with the slower, linear phase.   
 
TA protein targeting and translocation. For translation, a model substrate (N-
Sbh1p) was used, which contains an N-terminal flag tag, a fragment of MBP (to 
facilitate separation on SDS-PAGE) fused to yeast Sbh1p, a C-terminal bovine 
opsin tag for glycosylation, and optimized methionine content to increase signal:  
MDYKDDDDKMENAQKGEIMPNIPQMSAFWYAVRTAVINAASGRQTVDEAL 
KDAQTNSSSNNNNNNNNNNLGLVPRGSISEFGSSSPTPPGGQRTLQKRKQ 
GSSQKVAASAPKKNTNSNNSILKIYSDEATGLRVDPLVVLFLAVGFIFSV 
VALHVISKVAGKLFRMNGTEGPNMYMPMSNKTVD. 
The coding sequence for this protein was cloned into a transcription 
plasmid (Zhang et al., 2008) under control of an SP6 promoter. mRNAs were 
transcribed using the SP6 Megascript kit (Ambion). All translation and 
translocation assays were carried out as described in (Suloway et al., 2011). 35S-
methionine labeled pre- and glycosylated proteins were separated by 15% SDS-
PAGE and quantified by autoradiography using a Typhoon (GE Healthcare) 
phosphoimager and Image QuantTL (GE Healthcare).  Translocation efficiency 
(%glycosylated protein) was plotted as a function of Get3 concentration and fit 
to Eq 2.11, 
,    (2.11) 
Tobsd = To+Tmax ×
[Get3]h
[Get3]h +Kdh
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in which T0 is the fraction of translocation in the absence of Get3, Tmax is the 
maximal  amount of translocation with saturating Get3, Kd is the concentration 
of Get3 at half saturation, and h is the Hill co-efficient. 
 
TA protein capture by Get3 in translation extract. A Get3 pull-down assay in 
translation extract was performed. A 50 μl translation reaction in Δget3 lysate 
was initiated for 1 minute at 26 °C, at which time His6-tagged Get3 was added. 
After 40 min, the reaction mixture was adjusted with 20 mM imidazole and 1 mM 
cyclohexamide (final concentrations), followed by the addition of 10 μl Ni-NTA 
beads. After incubation on a rotating wheel at room 25 °C for 40 minutes, the 
beads were washed three times for five minutes in Get3 assay buffer with 30 
mM imidazole and 0.5 mM ATP, and eluted with SDS-PAGE buffer containing 
200 mM DTT and 300 mM imidazole. 
 
Complex formation by gel filtration: Complex formation between Get3 and 
Get4/5 was assayed using size exclusion chromatography (Superdex 200, GE 
Healthcare). To generate the complex, 13.3 µM of Get3 was incubated with 13.3 
µM of Get4/5 in Get3 assay buffer for 30 min at room temperature, with or 
without 200 µM ATP. Complex formation was assayed by following the 
depletion of the Get3 peak at ~14.8 ml. 
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Figures 
 
 
 
 
Figure 2.1 
Model for the ATPase cycle of Get3. T denotes ATP, D denotes ADP. The 
shapes depict various Get3 conformations. Steps 1–2, ATP binding and 
hydrolysis by a single active site in Get3. Step 3, ATP binding to a second active 
site of Get3. Step 4, ATP hydrolysis from dimeric Get3. Step 5, formation of the 
Get3 tetramer. Steps 6–7, ATP hydrolysis and ADP release from tetrameric 
Get3. Steps 8–9, release of ADP from the two active sites of Get3. The individual 
rate and equilibrium constants are listed in SI: Table S2.1. 
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Figure 2.2 
Cooperative ATP binding to Get3. (A) Single-site ATP hydrolysis by Get3. The 
data were fit to SI: Eq 2.7 and gave a KM of 37 ± 6.7 µM. (B) Equilibrium titration 
of mantATP (0.3 µM, black) and mantADP (0.3 µM, gold) binding to Get3 under 
single site conditions. The data were fit to SI: Eq 2.1. (C) ATP hydrolysis by Get3 
under multi-site conditions. The data were fit to SI: Eq 2.8 and gave a Hill 
coefficient of 2, average KM values of 3.0 ± 0.2, 3.6 ± 1.0 and 4.8 ± 0.2 µM, and 
observed kcat values of 0.26 ± 0.02, 0.33 ± 0.03 and 0.58 ± 0.03 min-1, 
respectively, for reactions with 0.2 (purple), 0.5 (blue), or 1.0 (black) µM Get3. (E) 
Summary of nucleotide binding and release kinetics. See also SI: Table S2.1. 
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Figure 2.3 
Tetramerization stimulates Get3’s ATPase activity and is required for TA protein 
targeting. (A) Observed kcat values as a function of Get3 concentration, for 
wildtype Get3 (black) and mutants Δ181-210 (green), P199D/M200D (pink), and 
M200D/L201D (blue). The data were fit to SI: Eq 2.9 and summarized in (D). (B) 
Structure of ScGet3 (PDB: 3A36) highlighting the residues mutated. The 
remainder of residues 181-210 is in green. (C) Targeting and insertion of Sbh1p 
by wildtype Get3. The data were fit to SI: Eq 2.11 and gave a Hill coefficient of 2. 
(D) Comparison of TA targeting efficiencies (open) and tetramer ATPase rate 
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constants (filled) for wildtype Get3 (black) and mutants P199D/M200D (pink), 
M200D/L201D (blue), and Δ181-210 (green). %translocation was normalized to 
wildtype Get3. 
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Figure 2.4 
Get4/5 tightens ATP binding to Get3 and inhibits ATPase activity. (A) Get4/5 
stoichiometrically inhibits Get3’s ATPase activity. Reaction contained 0.5 µM 
Get3 and 10 µM ATP. (B) ATP concentration dependence of ATPase activity at 
0.5 µM Get3, with (red) or without (black) 5 µM Get4/5 present. The data were fit 
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to SI: Eq 2.8 and gave average KM values of 3.7±0.2 and 1.4 ± 0.3 µM with and 
without Get4/5, respectively. (C) Kinetics of mantATP binding to Get3 with (red) 
and without (black) 3.0 µM Get4/5 present. The data were fit to SI: Eq 2.4. (D) 
Dissociation of mantATP from Get3 was slowed in the presence (red) of 3.0 µM 
Get4/5. (E) Observed kcat values as a function of Get3 concentration with (red) or 
without (black) 50 µM Get4/5 present. The data with Get3 were analyzed as in 
3(A), and the data with the Get3•Get4/5 complex were fit to a linear function. (F) 
Same as (E) but with Get3 mutants F190D (triangles) and I193D (squares) with 
(red) or without (black) Get4/5 present. Dotted lines are fits for wildtype Get3 in 
(E) and shown for comparison. All rate constants are reported in Tables S2.2 & 
S2.3. 
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Figure 2.5 
 TA substrate induces rapid ATP hydrolysis. (A) Pre-steady-state ATPase 
reaction at a 1:5 ratio of Get3/TA:ATP. The data were fit to SI: Eq 2.10. (B) ATP 
hydrolysis from the Get3/TA complex under single-turnover conditions. The data 
were fit to SI: Eq 2.7 and gave a kcat value of 0.42 min-1 and a KM value of 33 µM. 
(C) Kinetics of mantATP binding to the Get3/TA complex. Two phases were 
observed. The dashed part of the curve depicts theoretical increases in binding 
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rates at lower ATP concentrations where bi-molecular association is rate-
limiting, but which was inaccessible in our experiments. (D) MantADP 
dissociation from the Get3/TA complex. The data with Get3 (black) were from 
Figure S2.2F (black) and shown for comparison. All rate constants are reported 
in Table S2.2.  
 
 
Figure 2.6 
Model for TA protein targeting driven by the ATPase cycle of Get3, as described 
in the text.  
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Supplementary Figures 
 
Figure S 2.1 
Assays for ATP binding and hydrolysis by Get3, related to Figure 2.1 and Figure 
2.2. (A) Representative thin layer chromatography (TLC) analysis for monitoring 
the progress of a Get3 ATPase reaction (see Methods). Right panel shows 
quantification of the TLC data, which were fit to a single exponential function to 
obtain observed rate constants (kobsd). (B) Fluorescence emission spectra of 0.4 
µM mantATP with (red) or without (black) 35.8 µM Get3, and for the Get3-
mantATP complex chased with 2 mM ATP (blue). (C) Fluorescence emission 
spectra for 1.2 μM Get3 (donor, blue), 60 μM mantATP (acceptor, green), 1.2 µM 
Get3 incubated with 60 µM mantATP (donor + acceptor, red), or buffer (gray).
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Figure S 2.2 
Mant-ATP and mant-ADP binding and dissociation to Get3 related to Figure 2.1 
and Figure 2.2. (A) Competition of mantATP binding to Get3 by ATP, performed 
with 1.5 µM Get3, 8 µM mantATP, and varying concentrations of ATP as 
indicated. The data were fit to Eq 2.2 in Methods, which gave a Ki,app value of 4.5 
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μM. (B) Single-site time courses for mantATP (black) or mantADP (gold) binding 
to 37 µM Get3.  (C) Single-site observed association rate constants were plotted 
as a function of Get3 concentration.  Linear fits of the data (Eq 2.4) gave kon 
values of 0.20 ± 0.01 and 0.29 ± 0.02 µM-1s-1 for ATP (black) and ADP (gold), 
respectively. The values reported are the mean ± SD, with n = 3. (D) Multi-site 
time courses for binding of 13 µM mantATP (black) or mantADP (gold) to 1.5 µM 
Get3 using the FRET assay. (E) Multi-site observed nucleotide binding rate 
constants were plotted as a function of Get3 concentration.  Linear fits of the 
data gave kon values of 0.43 ± 0.04 µM-1 s-1 for ATP (black) and 0.31 ± 0.03 µM-1 
s-1 for ADP (gold). (F) Time courses for mantATP (black) or mantADP (gold) 
dissociation from Get3 under multi-site conditions. The data were fit to double 
exponential functions. Rate constants derived from the fast phase are reported 
in the text and table S2.1.  
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Figure S 2.3 
Controls for Get3 concentration-dependent ATPase stimulation, related to 
Figure 2.3. (A) Zoom-in of the dependence of observed kcat values at low Get3 
concentrations. Reactions were performed as in Figure 2.3A in the presence of 1 
mg/mL BSA (see methods). (B) Dependence of observed kcat of Get3 in assay 
buffer (circles, 50mM HEPES pH 7.4, 150mM potassium acetate, 5mM 
magnesium acetate, 1mM DTT and 10% glycerol) or purification buffer (squares; 
10 mM Tris, pH 7.5, 150 mM NaCl, 1 mM MgCl2). (C) Observed kcat values were 
determined as a function of Get3 concentration. The data with Get3 were 
analyzed as in (Fig. 2.3A) using Get3 mutants F190D (open triangles) and I193D 
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(closed squares).
 
Figure S 2.4 
Targeting and translocation of TA protein by wildtype and mutant Get3, related 
to Figure 2.3. (A) Cartoon diagram of the Get3 dependent TA targeting and 
translocation assay, as described in the Experimental Procedures and text. (B) 
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Get3-dependent targeting and translocation of Sbh1p, performed under 
identical conditions to Figure 2.3C, but in an independent experiment on a 
separate day using different Get3 concentrations. The data were analyzed as in 
Figure 2.3C and gave a Hill coefficient of 2. (C) Sbh1p targeting and 
translocation by wildtype and mutants P199D/M200D, M200D/L201D, and 
Δ181-210 at high Get3 concentrations. Gels for the data are on the right panel. 
(D) Capture of Sbh1p by wildtype Get3 (left) and mutant (Δ181-210) (right), using 
pulldown of His6-tagged Get3 by Ni-NTA beads as described in the 
Experimental Procedures.
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Figure S 2.5 
Get4/5 increases Get3’s affinity for ATP, and vice versa. Related to Figure 2.4. 
(A) Get4/5 stoichiometrically inhibits the ATPase activity of Get3. Reaction 
contained 16 µM Get3 and 320 µM ATP. (B) ATP concentration dependence of 
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observed ATPase activity at 1 µM Get3, in the absence (black) and presence 
(red) of 5 µM Get4/5. The data were fit to Eq 2.8 in the Extended Experimental 
Procedures, and gave average KM values of 3.6 ± 0.01 and 2.2 ± 1.0 µM, and kcat 
values of 0.43±0.003 and 0.18±0.04 min-1 with and without Get4/5, respectively. 
(C) Get3•mantATP dissociation kinetics, determined in the presence (red) or 
absence (black) of 3.0 µM Get4/5. Exponential fits of data gave dissociation rate 
constants of 14.4  s-1 and 11.3 s-1 with and without Get4/5, respectively. (D) Gel 
filtration chromatogram of apo-Get3 without (black) or with (red) Get4/5. Shown 
is a gel image for the fractions collected at ~11 ml. (E) Same as (D) but in the 
presence of saturating ATP.
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Figure S 2.6 
Purification and activity of the Get3/TA complex, related to Figure 2.5. (A) 
Purification of the recombinant Get3/TA complex over Superdex 200 (green). 
Maltose binding protein (MBP) was a cleavage product from MBP-tagged Get3 
during the purification, as described in the Methods. Chromatogram for dimeric 
Get3 is shown in black. Right panel shows SDS-PAGE analysis of the elution 
peak at ~10 ml, which contain both Get3 and Sbh1p. (B) Pre-steady-state 
ATPase reaction from the Get3/TA complex, performed as in Figure 2.6A but 
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with different ratios of Get3/TA complex relative to ATP: 1:10 (light green), 1:5 
(green), 1:2.5 (dark green). Data were analyzed as in Figure 2.5A.  (C, D) 
Representative time course for mantATP binding to the Get3/TA complex under 
multi-site (C) and single-site (D) conditions. Reaction in (C) used 2 µM Get3/TA 
complex and 13 µM mantATP and the obtained rate constants are plotted in 
Figure 2.6C. Reaction in (D) used 12.5 µM Get3/TA complex and 0.4 µM 
mantATP, and double exponential fit of the data gave rate constants of 0.4 s-1 
and 0.073 s-1. (E) Dissociation rate measurements for the Get3/TA complex in 
various nucleotide states. 2 µM Get3/TA was preincubated with 20 µM of the 
following: mantATP (black), mantADP (gold), mantAMPPNP (grey), and ADP + 10 
mM Pi (blue). Dissociation rate constants are reported in Table S2.2. 
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Figure S 2.7 
MantATP binding to Get3 is biphasic, related to Figure 2.2, and described in 
Extended Experimental Procedures. (A, B) Time course for mantATP binding to 
Get3 under single-site (A) and multi-site (B) conditions. The data were fit to 
double exponential functions. Rate constants derived from the fast phase are 
reported in the text. (C, D) Time courses for mantATP (C) or mantADP (D) 
dissociation from Get3 under multi-site conditions. The data were fit to double 
exponential functions. Rate constants derived from the fast phase are reported, 
as explained in the Methods. 
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Table S 2.1 
Summary of the rate and equilibrium constants during Get3’s ATPase cycle, 
related to Figures 2.1–3. The individual constants are defined in Figure 2.1. The 
values reported are the mean ± SD, with n = 3. 
 
Rate or equilibrium constants 
K1   12.4 ± 0.1 μM 
k1    (2.0 ± 0.1) × 105 M-1 s-1 
k-1     4.0 ± 0.3 s-1 
k2    Not determined 
K3     1.3 μM 
k3 ≥ (4.3 ± 0.4) × 105 M-1 s-1 
k-3     1.6 ± 0.1 s-1 
k4  ≥ 0.012 min-1 
K5     3.5 ± 1.9 μM 
k6     1.3 ± 0.4 min-1 
k8    (3.1 ± 0.3) × 105 M-1 s-1 
k-8   14.4 ± 0.9 s-1 
K9   11.7 ± 1.3 μM 
k9    (2.9 ± 0.2) × 105 M-1 s-1 
k-9     4.5 ± 0.6 s-1 
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Table S 2.2 
Summary of nucleotide dissociation rate constants from Get3 with and without 
effector proteins, related to Figures 2.4 and 2.5. The values reported are the 
mean ± SD, with n = 3. 
 
 
Nucleotide  
 
Effector 1
st Phase 2st Phase 
rate constant 
(s-1) 
amplitude 
(%) 
rate constant 
(s-1) 
Amplitude 
(% ) 
ATP (k-3) –   1.6 60 0.012 40 
ADP (k-8) – 14.4 56 0.015 44 
ATP  + Get4/5     0.15 40   0.0086 60 
ADP  + Get4/5 11.3 38 0.012 62 
ATP  + Sbh1     0.18    24.5 0.022   75.5 
ADP  + Sbh1     0.15    34.5 0.033   65.5 
ADP + Pi + Sbh1     0.14 39 0.036 61 
AMPPNP + Sbh1       0.214 40 0.032 60 
 
 
 
Table S 2.3 
Summary of ATPase rate constants from Get3 and Get3 TA binding mutants. 
related to Figure 2.3. The values reported are the mean ± SD, with n = 3. 
 
 
 F190D I193D 
ktetramer (min-1) 10.0 ± 1.5 10.1±1.6 
kdimer(min-1) 2.7±0.9 3.6±1.2 
Kd (µM) 0.37±0.4 0.26±0.4 
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Chapter 3 : Multiple Selection Filters Ensure Accurate Tail-
Anchored Membrane Protein Targeting 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A version of this chapter was first published as Meera Rao, Voytek Okreglak, Un 
Seng Chio, Hyunju Cho,  Peter Walter, Shu-ou Shan. Multiple selection filters 
ensure accurate tail-anchored membrane protein targeting. In Preparation  
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Abstract 
 Accurate protein localization is crucial to generate and maintain 
organization in all cells. Achieving accuracy is challenging, as the molecular 
signals that dictate a protein’s cellular destination are often promiscuous. A 
salient example is the targeting of an essential class of tail-anchored (TA) 
proteins, whose sole defining feature is a transmembrane domain near their C-
terminus.  Here we address how the Guided Entry of Tail-anchored proteins 
(GET) pathway selects TA proteins destined to the endoplasmic reticulum. 
Quantitative analyses define multiple physicochemical features that distinguish 
TA proteins destined to different organelles. Further, the GET pathway selects 
for these features at distinct stages using a variety of mechanisms including 
differential binding, induced fit, and kinetic proofreading after ATP hydrolysis by 
Get3. Our results also reveal new roles for the cochaperone Sgt2 in providing 
key selection filters, and provide a biological logic for the complex cascade of 
substrate relay events during post-translational membrane protein targeting.  
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Introduction 
 
Efficient and accurate localization of proteins is a prerequisite for the 
generation and maintenance of compartmentalization in all cells.  Understanding 
how protein-targeting pathways achieve highly accurate membrane protein 
localization has been challenging for multiple reasons.  First, topogenic signals 
that define a protein’s final destination tend to be degenerate and lack 
consensus motifs (Heijne, 1985; Zheng and Gierasch, 1996); this demands 
targeting machineries to be highly adaptable and able to recognize a diverse set 
of signals.  Second, only minor differences in signal sequences distinguish 
proteins that belong to alternative pathways or organelles (Emanuelsson and 
Heijne, 2001; Zhang and Shan, 2014; Zheng and Gierasch, 1996).  Thus, 
protein-targeting machineries must also evolve robust selection mechanisms 
that can detect these minor differences.  Furthermore, hydrophobic 
transmembrane domains (TMDs) on membrane protein substrates are prone to 
irreversible aggregation that can lead to mislocalization and proteostasic stress, 
requiring targeting machineries to also effectively shield the TMDs during 
targeting (Shao and Hegde, 2011).  With a few exceptions (see (Randall and 
Hardy, 1995; Zhang and Shan, 2014)), the molecular mechanisms by which 
protein targeting machineries overcome these challenges are not well 
understood for most pathways.   
A salient example of these challenges is provided by an essential class of 
tail-anchored (TA) membrane proteins, defined solely by a single TMD near the 
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C-terminus. TA proteins comprise 3-5% of the eukaryotic membrane proteome 
and play essential roles in numerous processes including membrane 
fusion/fission, vesicular trafficking, protein translocation, quality control, and 
apoptosis (Beilharz, 2003; Hegde and Keenan, 2011; Kalbfleisch et al., 2007).  
TA proteins are found in nearly all membranes in eukaryotic cells including the 
endoplasmic reticulum (ER), the mitochondrial outer membrane (OMM), and 
peroxisomes (Kutay et al., 1993). To a first approximation, the C-terminus of TA 
proteins (including the TMD) is necessary and sufficient to ensure their proper 
localization (Beilharz, 2003; Whitley et al., 1996), but the molecular information 
that directs TA proteins to diverse organelles is poorly understood.  Previous 
work has noted that modulation of the hydrophobicity of TMDs and basic 
residues at the extreme C-termini alter the localization of TA proteins to the ER 
versus mitochondria (Beilharz, 2003; Borgese et al., 2003; 2007; Rapaport, 
2003).  Nevertheless, whether and how these features are distinguished by 
protein targeting machineries remain poorly understood.  
Recent advances in understanding TA protein targeting pathways provide 
an opportunity to address this question.  Biochemical and genetic analyses have 
identified the Guided Entry of Tail-anchored protein (GET) pathway, which 
targets TA proteins destined to the ER through an elaborate series of substrate 
handoff events.  A co-chaperone, Sgt2, initially associates with the TMDs of TA 
proteins (Wang et al., 2010).  A scaffolding complex, comprised of Get4 and 
Get5 (Get4/5), bridges Sgt2 and the central targeting factor, the Get3 ATPase 
(Chartron et al., 2010; 2012c; Wang et al., 2010).  Get4/5 also preorganizes Get3 
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into the optimal conformation for TA binding (Gristick et al., 2014; Mateja et al., 
2015) and thus facilitates the transfer of TA substrates from Sgt2 to Get3 (Wang 
et al., 2010).  TA loading drives the dissociation of Get3 from Get4/5 and 
activates its ATP hydrolysis (Rome et al., 2014; 2013).  After ATP hydrolysis, the 
Get3•TA complex associates with a receptor complex on the ER membrane, 
comprised of Get1 and Get2, via which the TA protein is released from Get3 and 
inserted into the membrane (Schuldiner et al., 2008; Wang et al., 2014).   
While it has been established that the C-terminal TMD of a TA protein is 
sufficient for its association with both Sgt2 and Get3 (Hegde and Keenan, 2011; 
Wang et al., 2010), it is unclear how the GET pathway distinguishes TAs 
destined to different organelles and accurately selects the correct set of 
substrates.  We addressed these questions by systematically varying particular 
physicochemical properties of a TA protein, and quantitatively analyzing how 
each step in the GET pathway senses and responds to these variations through 
a combination of biochemical, biophysical, and cell biological studies.  Our 
results rigorously define at least two properties that distinguish TA proteins 
destined to different organelles, decipher multiple mechanisms by which these 
properties are selected by the GET pathway, and reveal new roles of Sgt2 in 
determining the specificity of TA selection.  
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Results 
 
TAs are targeted to the ER based on TMD hydrophobicity and C-terminal 
charges.  
Previous work suggests that a highly hydrophobic transmembrane 
domain (TMD) directs TA proteins to the ER (Burri and Lithgow, 2004; 
Kalbfleisch et al., 2007). A comprehensive analysis of the hydrophobicity score 
(Grand Average of Hydropathy (GRAVY) Calculator (http://www.gravy-calculator. 
de/)(Kyte and Doolittle, 1982) of TAs shows that: (i) the TMD of TAs span a wide 
range of hydrophobicity (Figure 3.1A); (ii) among these, well characterized GET 
substrates (Mateja et al., 2015; Schuldiner et al., 2008) (Figure 3.1A, highlighted) 
are enriched in the range of higher hydrophobicity; (iii) mitochondrial TAs tend to 
span a range of lower hydrophobicity, but exhibit significant overlap with that of 
GET substrates (Figure 3.1B; cf OMP25, MAVS, Fis1 versus Sec22, Ysy6 and 
Nyv1).  These observations suggest that features in addition to TMD 
hydrophobicity also dictate the localization of TAs.  A potential distinguishing 
feature is the enrichment of basic residues C-terminal to the TMD, which has 
been shown to direct proteins to OMM in Arabidopsis and mammalian cells 
(Marty et al., 2014; Yabal et al., 2003).  
To mechanistically understand how TA substrates are selectively targeted 
to the ER, we established a set of model TAs in which we systematically varied 
the hydrophobicity TMD and the positive charge in the C-terminal element 
(CTE). As model substrates destined to the ER and mitochondria, we focused on 
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the TMD and CTE of Bos1p (residues 207-244) and Fis1p, respectively (Figure 
3.2A). A non-cleavable, N-terminal 3xStrep-SUMO motif was fused to this 
sequence to enable purification and improve solubility of the substrate (Figure 
3.2A; see also (Wang et al., 2010; 2011a)).  We replaced increasing numbers of 
hydrophobic residues in the Bos1 TMD with Ala and Gly, creating a set of 
substrates that span the overlapping range of hydrophobicity between 
mitochondrial and ER-destined TAs (Figure 3.2A and 3.1C).  In addition, we 
swapped the TMDs and CTEs of Bos1p and Fis1p (Figure 3.2A, Fis1-FisC) and 
systematically varied the number of basic residues in the CTE to isolate the 
contribution of C-terminal charges (Figure 3.2A).  
To test if the GET pathway can select substrates based on these features 
and whether this selection can be recapitulated in vitro, we measured the ability 
of purified Get3 to target and translocate TA substrates into ER microsomes in a 
∆get3 yeast lysate (Rome et al., 2013; Wang et al., 2010) (Figures 3.2B-E). 
Successful translocation into ER enables glycosylation of an opsin tag fused to 
the C-terminus of substrates (Figure 3.2A), providing a semi-quantitative 
measure for targeting and translocation efficiency (Rome et al., 2013).  Of the 
TAs that had altered TMDs, 2AG was translocated as efficiently as Bos1; 3AG, 
4AG, and 5AG underwent Get3-dependent insertion but exhibited increasing 
defects; and 6AG abolished Get3-dependent translocation (Figures 3.2B-C).  
Replacement of the CTE of Bos1 with an increasing number of Arg residues 
(Bos-RR and Bos-RRRR) or with the charged Fis1-CTE (Bos1-FisC) also 
substantially reduced Get3-dependent translocation (Figure 3.2D).  Reciprocally, 
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reducing the charges in the CTE of Fis1-FisC by replacing it with the Bos1 CTE 
or with two Args enhances TA insertion into ER, whereas replacing the CTE with 
four Args retained the low level of ER insertion of the TA substrate (Figure 3.2E). 
Thus, efficient TA targeting to the ER depends on both the TMD and positive 
charges in the CTE, and these dependences can be recapitulated in the GET 
pathway using this set of model substrates. 
Several additional observations can be made from these data.  First, the 
translocation defects of 3AG, 4AG, and 5AG are more pronounced at low Get3 
concentrations but can be rescued by higher amounts of Get3 to levels 
comparable to that of Bos1 (Figure 3.2C).  In contrast, the translocation of Bos1-
CTE mutants saturated at ≤ 0.5 µM Get3 and was not further improved by 
higher Get3 concentration (Figure 3.2D).  This suggests that distinct 
mechanisms are used to reject a suboptimal TMD versus CTE of TA substrates; 
this hypothesis is further supported by in-depth analyses below.  Second, 
substrates containing a Fis1 TMD exhibited Get3-independent insertion into ER 
microsomes, and insertion was abolished by a highly charged CTE (Fis1-FisC or 
Fis1-RRRR) (Figure 3.2E). This suggests the presence of additional pathways 
that could target TA proteins with suboptimal TMDs to the ER, and more 
importantly, that a positively charged CTE serves as a general feature to reject 
TA proteins from the ER in both GET-dependent and GET-independent 
pathways.   
 
Sgt2 discriminates TAs based on TMD hydrophobicity 
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To understand how substrates are selected by the GET pathway, we 
dissected the individual molecular steps in this pathway.  To this end, we 
adapted an E. coli in vitro translation system (Goerke and Swartz, 2009; Jewett 
and Swartz, 2004). Highly efficient translation in this lysate provides a robust 
source of TA proteins.  Further, the lack of  GET homologues in bacteria makes 
this lysate a bio-orthogonal system in which all the molecular steps in the GET 
pathway can be reconstituted using purified components.  
The first known step in the GET pathway is the capture of TA substrates 
by the co-chaperone Sgt2.  To understand whether and how TA substrates are 
distinguished during this step, we translated TA proteins in E. coli lysate in the 
presence of 35S-methionine and His6-tagged Sgt2, and analyzed the amount of 
TA substrate associated with Sgt2 after affinity-capture with Ni-NTA (Figure 
3.3A).  To provide better quantification and reduce variability, each substrate 
was translated and captured together with a smaller Bos1 construct lacking the 
3xStrep tag (Ctrl).  Both the substrate and Ctrl can be visualized on SDS-PAGE 
and autoradiography (Figure 3.3B), and the capture efficiencies of the substrates 
of interest were directly normalized against Ctrl.  The only exception was the 
experiment with Fis1-FisC, in which the 3xStrep tag was placed on the control 
(Ctrl+3xStrep) rather than Fis1-FisC (Fis1-FisC∆). This change was necessary to 
enhance the translation of Fis1-FisC, but otherwise did not affect the outcome 
or interpretation of the experiment. 
The results showed that, compared to Bos1, 2AG and 3AG were 
captured by Sgt2 with comparable efficiency and 4AG, 5AG and Fis1-FisC 
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exhibited statistically significant defects, whereas 6AG was poorly captured by 
Sgt2 (Figures 3.3B and C).  There is a good agreement between the GRAVY 
scores of these TMD variants and their efficiencies of capture by Sgt2 (Figure 
3.1C versus 3C).  On the other hand, Bos1-FisC was captured by Sgt2 as 
efficiently as Bos1, indicating that a positively charged CTE does not affect TA 
binding to Sgt2.  Thus, the efficiency of TA capture by Sgt2 is highly sensitive to 
the hydrophobicity of the TMD, but not to basic residues at the extreme CTE. 
 
Fis1 is rejected during TA transfer from Sgt2 to Get3  
 In the next step of the pathway, TA substrates are transferred from Sgt2 
to Get3 with the help of the Get4/5 complex. To quantitatively understand this 
substrate handover event, we developed an assay based on Förster Resonance 
Energy Transfer (FRET). Using an E. coli translation lysate that harbors a pair of 
engineered amber suppressor tRNA and tRNA synthetase, a fluorescent 
unnatural amino acid, 7-hydroxycoumaryl ethylglycine (Cm), was efficiently and 
site-specifically incorporated into the TA substrate during translation (Figures 
3.4A, 3.4B and 3.5B) (Charbon et al., 2011; Saraogi et al., 2011a).  Cm was 
incorporated four residues upstream of the TMD of TA substrates and served as 
the FRET donor (denoted as TACm).  As the FRET acceptor, CoA-BODIPY-FL 
was enzymatically conjugated to ybbR-tagged Get3 via the Sfp 
phosphopantetheinyl transferase enzyme and CoA chemistry (Figure 3.4E-G; 
(Yin et al., 2006)).  BODIPY-FL-labeled Get3 (denoted as Get3BDP) exhibits 
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translocation and ATPase activities comparable to those of wildtype Get3 
(Figures 3.4H-I).   
To reconstitute TA transfer from Sgt2 to Get3, we generated and affinity 
purified Sgt2•TACm complexes (Figure 3.4C-D) and incubated the complex with 
Get4/5, ATP, and Get3 to allow TA transfer (Figure 3.5A).  We observed a 52% 
reduction in Cm fluorescence when the transfer reaction was carried out with 
Get3BDP but not with unlabeled Get3 (Figure 3.5B), indicating a high efficiency of 
both TA transfer and FRET between TACm and Get3BDP.  
Using this FRET assay, we asked whether the transfer of substrates from 
Sgt2 to Get3 is specific for ER-destined TA proteins.  First, we measured FRET 
when the transfer reaction was allowed to reach equilibrium at varying 
concentrations of Get3BDP (Figure 3.5C). These titrations showed that the 
equilibrium of TA transfer between Sgt2 and Get3, quantified empirically by the 
concentration of Get3 required for 50% transfer (denoted as K1/2), varied 
modestly (< 3-fold) among all the substrates tested (Figure 3.5D and Table 3.2). 
Thus at equilibrium, the preference of Get3 for these TA variants closely parallels 
that of Sgt2, such that the transfer of TA from Sgt2 to Get3 is largely 
isoenergetic for this set of TA variants.  
Real-time measurement of TA transfer from Sgt2 to Get3 showed that the 
Get4/5 complex significantly accelerated the substrate transfer process (Figure 
3.5E), and revealed two kinetic phases during this transfer.  For Bos1, the rate 
constants of the fast and slow phases are 0.0094 s-1 and 0.003 s-1, respectively, 
in the absence of Get4/5, and increased to 0.047 s-1 and 0.011 s-1, respectively, 
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in the presence of Get4/5 (Figures 3.5E and Table 3.2).  As no kinetic phases 
characteristic of the Get4/5-independent reaction were observed during Get4/5-
dependent TA transfer, this ruled out the possibility that the slow phase 
observed during the latter reaction arose from TAs that underwent Get4/5-
independent transfer.  Finally, highly efficient TA transfer was observed even 
when the reaction was carried out in the presence of ribosome-depleted Dget3 
lysate (Figure3. 5H), strongly suggesting that Get4/5-dependent TA transfer is 
robust and can withstand competition from other cellular factors.  
The set of TA variants, in which the hydrophobicity of the TMD is 
systematically altered (Bos1 – 5AG), varied modestly in their kinetics of Get4/5-
dependent transfer to Get3.  The rate constants of both the fast and slow 
phases varied approximately 4-fold among these substrates, with TAs 
containing less hydrophobic TMDs exhibiting higher rate constants in each 
phase (Figure 3.5F).  These effects were offset, however, by the larger 
contribution of the fast phase to the transfer reaction of the more hydrophobic 
substrates (Figure 3.5G and Table 3.2).  Surprisingly, the TA transfer reaction 
was completely abolished for Fis1-FisC (Figure 3.5E), consistent with the Get3-
independence of the TA insertion reactions for substrates containing the Fis1-
TMD (Figure 3.2E).  In contrast, Bos1-FisC exhibited transfer kinetics 
comparable to that of Bos1 (Figure 3.5F-G), indicating that the Fis1-TMD, rather 
than its charged CTE, is responsible for the observed rejection of Fis1-FisC 
during TA transfer. Together, these results showed that a less hydrophobic TMD 
poses a modest barrier for TA handover from Sgt2 to Get3 and the Fis1-TMD 
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are strongly discriminated during this transfer reaction, whereas the C-terminal 
positive charges are not recognized by the GET pathway at this stage. 
 
C-terminal basic residues slow TA insertion into ER. 
In the last stage of the GET pathway, the Get3•TA complex is targeted to 
the Get1/2 receptors on the ER and the TA substrate is inserted into the 
membrane.  To reconstitute this step, we generated 35S-methionine labeled TAs 
during in vitro translation in the presence of Sgt2, Get4/5 and His6-tagged Get3 
and affinity purified Get3•TA complexes using Ni-NTA. Purified complexes were 
presented to ER microsomes derived from ∆get3 yeast, and the efficiency of 
targeting and insertion was assessed by glycosylation (Figures 3.6A-C).  Real 
time measurement of the insertion reaction showed that 2AG, 3AG, 4AG, and 
5AG were targeted and inserted with similar kinetics and efficiency as Bos1 
(Figures 3.6B-C).  6AG showed a marked reduction in insertion efficiency at 
steady state but not in the rate to reach the steady state (Figure 3.6D). In 
contrast, Bos1-FisC, Bos1-RR, and Bos1-RRRR showed significant reductions 
in both the level of translocation at steady state and the rate to reach steady 
state compared to Bos1, mirroring their translocation defects observed in the 
complete yeast lysate. Bos1-RR showed a reduction in the rate to reach steady 
state compared to Bos1 (see Figure 3.3).  
Further analyses of the kinetics of TA insertion strongly suggest that the 
observed translocation defects of 6AG and Bos1-FisC arise from different 
mechanisms.  During the observed insertion reaction, the productive targeting 
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and insertion processes (Figure 3.6F, kinsert) must compete with nonproductive 
events (knonproductive) including the reversal of this reaction or more likely, 
disassembly of the Get3•TA complex (kdis) which could lead to aggregation of 
the TA substrate (kagg).  The observed rate constant of the insertion reaction 
(kobsd) is the sum of the rate constants for insertion from the Get3/TA complex 
and competing nonproductive reactions.  The level of insertion at steady state 
reflects how fast the insertion reaction is compared to the nonproductive 
reactions (see Methods).  Dissection of the observed reaction kinetics into these 
components showed that the observed translocation defect of 6AG arises 
primarily from a much faster rate of nonproductive reactions (Figure 3.6G, open 
bar). In contrast, the observed defects of Bos1-RR, Bos1-FisC, and Bos1-RRRR 
arise primarily from a much slower rate of insertion into the ER (Figure 3.6 G-H, 
solid bars).  Thus, the TA insertion step provides the main selection mechanism 
by which substrates with charged CTE are rejected from the ER. 
A likely source of the nonproductive reactions is the disassembly of the 
Get3•TA complex, which can lead to TA aggregation and/or misfolding.  To test 
whether this was the case, we directly measured the kinetic stability of the 
Get3•TA complex.  We generated and purified Get3•TA complexes as for the 
insertion reaction, except that TA and Get3 were labeled with Cm and BODIPY-
FL, respectively.  The rate constant for disassembly of the Get3•TA complex 
was measured using pulse-chase experiments and monitored by loss of FRET 
between TACm and Get3BDP.  The results showed that, with the exception of 6AG, 
dissociation of the Get3•TA complexes are extremely slow, at a rate constant of 
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~3 x 10-4 s-1 (or half time of ~ 40 min), for most of the substrates tested (Figure 
3.6I).  In contrast, 6AG dissociates from Get3 with a rate constant of 3x10-3 s-1 
(or half time of ~ 4 min), in close agreement with the rate of nonproductive 
reactions calculated from the translocation data (Figure 3.6G and Table 3.3). 
Thus, Get3 binds tightly to most TA substrates with TMDs above a modest 
degree of hydrophobicity, such that dissociation of the Get3•TA complex is 
much slower than its subsequent targeting and insertion. Only less hydrophobic 
substrates such as 6AG exhibit significantly faster dissociation from Get3, which 
competes effectively with the insertion of TA protein into the ER. 
 
Sgt2 enhances specificity of the GET pathway. 
 The analyses above strongly suggest that Sgt2 plays important roles in 
discriminating against TAs with suboptimal TMDs before they are loaded onto 
Get3. To more directly test this idea, we prepared yeast lysate using the 
SGT2FLAG/∆get3 strain and immuno-depleted Sgt2-Flag using anti-FLAG resin 
(Figure 3.7A).  We tested the overall targeting and insertion of Bos1 and 5AG in 
the Sgt2-depleted lysate. A mock-depleted ∆get3 lysate was also tested as a 
positive control.  The results showed that in the mock-depleted lysate, Bos1 
was targeted and inserted 2.5-fold more efficiently than 5AG (Figure 3.7B-C), 
whereas this difference was significantly smaller in the Sgt2-depleted lysate 
(Figure 3.7B-D). These results provide independent evidence for selection 
mechanisms upstream of TA loading on Get3 that help reject 5AG from the GET 
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pathway. Thus, Sgt2 plays a critical role in enhancing discrimination against 
suboptimal substrates. 
 
The charge at the CTE significantly alters organellar localization of Fis1 
While the role of TMD in directing proteins to ER versus mitochondria has 
been extensively studied in vivo (Borgese et al., 2001; 2003; 2007; Marty et al., 
2014; Pedrazzini, 2009), the role of the CTE in distinguishing mitochondria and 
ER-destined TAs is far less well characterized.  To more systematically 
understand the importance of the basic CTE, we examined the in vivo 
localization of CTE variants of a Fis1 fused to GFP. As previously reported 
(Habib et al., 2003), the TMD and the basic CTE of Fis1 (Figure 3.8, Fis1-TMD-
CTE) are sufficient to direct GFP to the OMM and peroxisomes and exclude its 
accumulation in the ER. Deletion of the CTE leads to a loss of specific 
mitochondrial targeting and the accumulation of Fis1-TMD in the ER, as shown 
by the co-localization of GFP with the ER marker Sec63 tagged with tdTomato 
(Figure 3.8, Fis1-TMD). We next probed the minimal charge requirement of the 
CTE that provides mitochondrial specificity and excludes Fis1-TMD from the ER. 
To this end, we created variants of Fis1-CTE with increasing numbers of 
arginine residues (Figure 3.8, Fis1-TMD-Rn) and quantified their co-localization 
with Sec63-tdTomato and mitochondrially targeted TagBFP (mito-TagBFP). 
These data show that when the net positive charge on the CTE reached +4 
(Figure 3.8, Fis1-TMD-RRRR), equivalent to that of the native CTE, specific 
mitochondrial localization was fully restored. Thus, the net charge of the CTE 
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plays an important role in providing a selectivity filter to exclude mitochondria-
destined TA proteins from the ER.    
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Discussion 
 
Accurate protein localization is essential for cells to establish and 
maintain compartmentalization. TA proteins, with a C-terminal TMD as their only 
defining feature, pose special challenges for protein targeting pathways that 
need to sort these proteins to the correct cellular membranes. In this work, 
systematic analyses corroborate previous observations (Borgese et al., 2007; 
Marty et al., 2014; Whitley et al., 1996) and rigorously define at least two 
physicochemical properties, the hydrophobicity of the TMD and basic residues 
at the extreme C-termini, which distinguish TA proteins destined to different 
organelles.  For the first time, we define multiple, distinct mechanisms that allow 
the GET pathway to recognize these properties and select for the correct 
substrates.  These findings also reveal new roles of the co-chaperone Sgt2 and 
rationalize, in part, the chemical and biological logic for the complex series of 
substrate handover events in this targeting pathway. 
In the initial entry into the GET pathway, capture of TA proteins by Sgt2 
provides the first selection filter that discriminates substrates based on 
hydrophobicity (Figure 3.9A, Step 1).  TA substrates with increasing number of 
Ala/Gly replacements in the TMDs form decreasingly stable complexes with 
Sgt2 (this work, (Wang et al., 2010)).  The good agreement between the TA 
capture efficiency by Sgt2 and the GRAVY scores of the TMD variants tested 
here strongly suggests that overall hydrophobicity is the dominant feature 
recognized by Sgt2.  On average, the TMDs of TA proteins destined to the OMM 
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have hydrophobicity comparable to or lower than those of the 4AG substrate 
examined here, and many could be partially or completely rejected from the GET 
pathway at this step. Nevertheless, Sgt2 is insensitive to enrichment of basic 
residues at the extreme C-terminus that characterizes some mitochondrial TAs, 
suggesting that this property must be detected by other mechanisms.   
The handover of TA proteins from Sgt2 to the central targeting factor, 
Get3, provides a second selection filter in the pathway (Figure 3.9A, Step 2).  
Intriguingly, substrate discrimination based on hydrophobicity of the TMD or 
charges in the CTE is fairly modest during this transfer.  In contrast, the TMD of 
Fis1p is completely rejected during the transfer of TAs from Sgt2 to Get3.  This 
rejection, combined with the suboptimal capture of this substrate by Sgt2, is 
sufficient to account for the Get3-independence of the insertion reactions for 
substrates containing the Fis1-TMD in yeast lysate.  This is surprising, as the 
hydrophobicity of Fis1p-TMD is comparable to those of 4AG and 5AG (which 
were efficiently transferred to Get3), and strongly suggests that another 
physicochemical property is responsible for TA substrate discrimination during 
their transfer to Get3.  A possible candidate is the helical propensity of the TMD, 
as secondary structure predictions suggest that the additional Gly/Ser residues 
in the Fis1-TMD introduce breakages in the helix, and as the substrate binding 
groove of ATP-bound Get3 appears preorganized for interaction with a helical 
TMD (Mateja et al., 2015).  Regardless of the exact nature of this property, our 
observations indicate that substrate transfer from Sgt2 to Get3 provides a 
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strong selection filter against the mitochondrial protein Fis1p, and that a distinct 
property in the TMD is recognized during this handover event.  
Targeting of the Get3TA complex to the ER and TA insertion into the 
membrane provides an additional selection filter (Figure 3.9A, Step 3).  Our 
results show that two mechanisms can lead to further rejection of suboptimal 
substrates at this stage.  TA proteins with low hydrophobicity, such as 6AG, 
dissociate from Get3 much more quickly than those with more hydrophobic 
TMDs; thus, disassembly of the targeting complex competes effectively with 
productive targeting and insertion.  More importantly, this step provides the 
major mechanism to reject TA proteins with highly basic CTE, which are inserted 
into the ER much more slowly than those without (Figure 3.9A and 9C, blue). As 
the charged CTE compromised both Get3-dependent and Get3-independent TA 
insertions into the ER, enrichment of basic residues in the CTE provides a 
general feature that enables TA substrates with relatively hydrophobic TMDs to 
escape delivery and insertion to the ER.  As transporting charges across a 
hydrophobic environment poses a high energetic barrier, this could provide an 
effective mechanism to reject substrates using either the phospholipid 
membrane at the ER and/or translocases that provide no compensation for 
these charges.  Indeed the barrier for transport charges is higher for ER 
substrates than mitochondrial substrates as the outer membrane of 
mitochondria has an enrichment of the anionic lipid, cardiolipin (Gebert et al., 
2009; van Meer et al., 2008). Finally, a four leucine substitution in the Fis1 TMD 
could compensate for its charged CTE and re-direct Fis1 to the GET pathway 
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(Wang et al., 2010), suggesting that TA localization is specified by a balance 
between multiple physicochemical properties.   
The GET pathway uses a variety of molecular strategies to select for the 
correct substrates and reject suboptimal TAs.  Selection during the initial 
capture utilizes the difference in binding energy of various TAs for Sgt2.  
Selection during substrate handover to Get3 utilizes an induced-fit mechanism, 
in which correct substrates enable faster reactions than incorrect substrates.  
After TA loading onto Get3, these substrates further partition between 
disassembly from Get3 and productive insertion into ER, with authentic 
substrates partitioning more favorably into the productive insertion reaction than 
suboptimal substrates. As this partitioning occurs after irreversible ATP 
hydrolysis on Get3, it is analogous to proofreading mechanisms observed 
during rejection of near cognate tRNAs by the ribosome (Rodnina and 
Wintermeyer, 2001a; 2001b). Although each mechanism provides a finite 
discrimination, the use of multiple, sequential selection steps can generate 
substantial accuracy despite the small differences that distinguish TA proteins 
destined to different organelles. This principle has been observed with DNA and 
RNA polymerases (Sydow and Cramer, 2009), in translation elongation by the 
ribosome  (Ogle and Ramakrishnan, 2005; Rodnina and Wintermeyer, 2001a), 
and in co-translational protein targeting mediated by the signal recognition 
particle (Zhang et al., 2010), and may represent a general principle by which key 
biological processes attain a high degree of fidelity. 
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Our results also reveal an important role of Sgt2 in the selection and 
commitment of TA substrates to the GET pathway. Counter-intuitively, 
differences in binding affinity of different TA substrates to Get3 do not provide a 
stringent selection mechanism. This is due to the high kinetic stability of the 
Get3-TA interaction, such that dissociation of the Get3•TA complex (τ ~ 1 hr) is 
much slower than its subsequent targeting and insertion (t ~ 5–7 min). As a 
result, TA proteins of borderline hydrophobicity that modestly destabilize the 
Get3TA complex would not be filtered out of the pathway (Figure 3.9B). Sgt2 
could overcome this problem by two mechanisms. First, as Sgt2 forms less 
stable complexes with TA proteins, a borderline substrate bound to Sgt2 can 
more readily equilibrate with alternative machineries in the cytosol than if the 
same substrate were bound to Get3. In addition, Sgt2 poses a higher kinetic 
barrier for transferring borderline substrates to Get3. Thus, Sgt2 imparts two 
important selection filters upstream of Get3. This provides, in part, a rationale for 
the complexity of TA protein loading and substrate handover events in the GET 
pathway.  
 Additional mechanisms could further enhance selection accuracy by the 
GET pathway.  A simple extension of our model could include factors that 
compete with Get3 for receiving substrates from Sgt2, thus introducing a branch 
point upstream of Get3 that irreversibly directs suboptimal substrates from the 
GET pathway. The mammalian Sgt2 homolog, SgtA, associates with the Bag6 
complex. Although the C-terminal domain of Bag6, together with TRC35 and 
Ubl4A, provides a structural analogue of the Get4/5 complex to mediate TA 
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substrate transfer to TRC40 (the mammalian Get3 homologue) (Mock et al., 
2015), Bag6 also contains additional domains that mediate membrane protein 
quality control (Hessa et al., 2011). Thus, Bag6 provides a strong candidate to 
provide such a branch-point that can direct suboptimal substrates from the 
TRC40/GET pathway and towards quality control machineries (Lee and Ye, 
2013; Leznicki and High, 2012).  Analogous branches have been suggested by 
physical interactions between Sgt2 and other factors (Kohl et al.; Wang et al., 
2010) but the mechanistic details of these and other machineries could exist in 
yeast and await discovery. 
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Materials and Methods 
 
Strains, plasmids and transcripts. Yeast strains used for live-cell imaging are 
derivatives of W303 (ATCC201238) but were made TRP1 and ADE2 by repairing 
the endogenous auxotrophies. GFP-Fis1-tail constructs were made by PCR 
amplifying GFP(S65T) which lacks a stop codon, with flanking SpeI and HindIII 
sites, the C-terminal 102 nt of Fis1 (plus additions for arginine codons and a 
stop codon included in the 3’ oligo) with flanking HindIII and XhoI sites and 
cloning both fragments into p416ADH. mt-TagBFP is described in (Okreglak and 
Walter, 2014) and Sec63-tdTomato was a kind gift of Sebastian Schuck, ZMBH, 
Universität Heidelberg.  
 A model substrate is comprised of three tandem Strep tags at the N-
terminus, a mutant yeast Smt3 in which the Ulp1 cleavage site was removed (a 
Pro insertion at residue 98 of Smt3), residues 207-222 of Bos1p 
(SEQTITSINKRVFKDK), various TMDs and CTEs defined in Figure 3.3A, and an 
opsin tag at the extreme C-terminus (GSMRMNGTEGPNMYMPMSNKTVD). 
TMD and CTE variants were constructed using Quikchange mutagenesis 
(Stratagene) or FastCloning (Li et al., 2011). For translation in yeast lysate, the 
coding sequences for model TA substrates were cloned into pSPBP6 (Siegel 
and Walter, 1988) under control of the SP6 promoter, and transcribed using a 
SP6 Megascript kit (Ambion).  For coupled transcription-translation in E. coli 
lysate, the substrate coding sequences were cloned into the pCAT vector (Kim 
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and Swartz, 2001) to replace that of chloramphenicol acetyl transferase.  pET29-
Sfp-His6 was a gift from Jun Yin. 
Cell imaging.  Yeast strains were cultivated in SD –Trp lacking the appropriate 
nutrients for selection of episomal constructs at 25 ºC at early to mid-log phase 
(OD600 ~ 0.3-0.5). Cells were immobilized on coverslips coated with 0.1 mg/ml 
concanavalin A (Sigma) and imaged using a Nikon Eclipse Ti equipped with a 
spinning disk confocal (CSU-X1; Yokogawa), EMCCD camera (iXon3 897; 
Andor) and a 100X 1.49NA objective. Images were acquired with μManager 
software (Edelstein et al., 2010) and processed with ImageJ 1.49 
(http://rsb.info.nih.gov/ij/).  
 
Translation Extracts.  Yeast translation extracts and microsomes were 
prepared from Dget3 or SGT2FLAG/∆get3 (VDY 57; (Wang et al., 2010) strains 
as described in (Rome et al., 2013). E. coli S30 lysate was prepared as 
previously (Saraogi et al., 2011b). Coupled transcription-translation in the S30 
extract was carried out as described (Saraogi et al., 2011b) except that 
untagged T7 polymerase and untagged CmRS was used and anti-ssrA oligo 
was omitted.  
 
Protein expression and purification. Expression and purification of full length 
Get4/5 and His6-tagged Get3 were performed as described (Rome et al., 2013). 
His6-tagged Sfp was expressed and purified as described (Yin et al., 2006). 
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Purification of His6-tagged Sgt2.  A hexahistidine tag and TEV protease site were 
fused to the N-terminus of full length Sgt2 and cloned into pET33b. Proteins 
were expressed in BL21DE3* at 37ºC for 4 hours after induction with 0.4 mM 
IPTG.  Cell pellets were resuspended in 50 mM Tris-HCl (pH 7.5), 500 mM NaCl, 
30 mM imidazole, 5 mM β-mercaptoethanol (β-ME), 1X cOmplete Tablets EDTA 
free Protease Inhibitor Cocktail (Roche), Benzonase (Novagen), and lysed in 1X 
BugBuster® (Novagen).  Clarified lysates were loaded on Ni Sepharose resin 
(GE Healthcare) and washed with 30 column volumes of lysis buffer.  Proteins 
were eluted using 50 mM Tris-HCl (pH 7.5), 500 mM NaCl, 300 mM imidazole 
and dialyzed against 50 mM KHEPES (pH 7.5), 150 mM NaCl and 20% Glycerol.  
Purification of untagged Sgt2. Full length Sgt2 is flanked by N-terminal and C-
terminal TEV sites. A His6-tag was inserted downstream of the C-terminal TEV 
site.  This construct was cloned into pMALC2 as a C-terminal fusion to the MalE 
gene. Protein was expressed and purified as with His6-tagged Sgt2 with the 
following modifications: after affinity purification by Ni-NTA (QIAGEN), protein 
was dialyzed against 20 mM Tris-HCl (pH 7.5), 20 mM NaCl and 1 mM β-ME. 
TEV protease was included with partially purified Sgt2 to remove the MBP and 
His6 tags.  Samples were then incubated with amylose resin to remove MBP and 
MBP-fusion proteins. The flowthrough was further purified by anion exchange 
MonoQ 10/100 GL (GE Healthcare) using a gradient of 20 –550 mM NaCl, 
followed by gel filtration chromatography on a Superdex 200 16/60 (GE 
Healthcare) in GET Buffer (50 mM KHEPES (pH 7.5), 150 mM KOAc, 5 mM 
Mg(OAc)2, and 1 mM DTT). 
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Purification of ybbR-tagged Get3.  Amplified DNA encoding wild-type S. 
cerevisiae Get3 was subcloned into pET28-His6-thrombin-SUMO vector (a gift 
from André Hoelz) using SalI and NotI restriction sites. For Sfp-mediated 
labeling, a ybbR tag (DSLEFIASKLA) was inserted between residues S110 and 
D111 in the His6-Thrombin-SUMO-Get3 construct through FastCloning (Li et al., 
2011). SUMO-Get3 proteins were recombinantly expressed in E. coli BL21 DE3* 
cells grown in LB media for 6-8 hours at 25 °C after induction with 1 mM IPTG 
when cultures reached an A600 ~ 0.3-0.6. The fusion protein was purified first 
using Ni-NTA affinity chromatography (Qiagen), and incubated with SUMO 
protease (gift from André Hoelz). The digestion mixture was passed through Ni-
NTA to remove His6-thrombin-SUMO and SUMO protease.  Dimeric Get3 was 
further isolated by gel filtration over Superdex 200 16/60 (GE Healthcare). For 
ATPase assays, Get3 was further purified over MonoQ 10/100 GL (GE 
Healthcare) before gel filtration chromatography. 
Purification of untagged T7 polymerase. A precision protease site was 
introduced between the N-terminal His6-tag and T7 polymerase. After 
purification of His6-tagged T7 polymerase via Ni-NTA, the elution was dialyzed 
overnight against 50 mM Tris-HCl (pH 8.0), 200 mM NaCl, 5% Glycerol, and 10 
mM imidazole at 4 ºC in the presence of His6- tagged precision protease (a gift 
of Andre Hoelz). The mixture was passed through Ni-NTA to remove the 
precision protease and further purified over Superdex 200 16/60 (GE 
Healthcare). Purified T7 polymerase was stored in 50% glycerol at –30 ºC.  
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Purification of untagged coumarin-tRNA synthetase (CmRS). A precision 
protease site was introduced between the N-terminal His6-tag and CmRS 
(Charbon et al., 2011; Saraogi et al., 2011b). After purification of His6-tagged 
CmRS via Ni-Sepharose (GE Healthcare), the elution was dialyzed overnight 
against 25 mM KHEPES (pH 7.5), 300 mM NaCl, 10% Glycerol, 10 mM β-ME, 
and 50 mM imidazole at 4 ºC in the presence of His6-tagged precision protease 
(a gift of Andre Hoelz). The mixture was passed through Ni-Sepharose to 
remove the precision protease and undigested CmRS. Purified CmRS was 
stored in 50% glycerol at –30 ºC.  
 
Fluorescence labeling 
Synthesis and purification of Bodipy FL-CoA. Bodipy FL-CoA was synthesized 
and purified as described (Yin et al., 2006) with the exception that Bodipy FL 
maleimide (Life Technologies) was used instead of Alexa Fluor 488 C5 
maleimide. The lyophilized compound was dissolved in DMSO, and dye 
concentration was quantified after dilution in methanol using ε504 = 79,000 M-
1cm-1.  
Labeling of ybbR-Get3 with Bodipy FL-CoA. 30 µM ybbR-Get3 was mixed with 
60 µM Bodipy FL-CoA and 12 µM Sfp-His6 in Sfp labeling buffer (50 mM 
KHEPES, pH 7.4, 10 mM MgCl2) in a total volume of 800 µL. The reaction 
mixture was rotated at room temperature for 1 hour. 10 µL 2 M imidazole (pH 
7.0) was added before passing the reaction through Ni-NTA to remove Sfp-His6. 
Gel filtration through a Sephadex G-25 (Sigma-Aldrich) column was used to 
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remove excess Bodipy FL-CoA and exchange ybbR-Get3BDP into GET buffer.  
Translocation and ATPase reactions mediated by ybbR-Get3BDP were performed 
as described in (Rome et al., 2013). 
Purification of Sgt2TACm. 7-hydroxycoumarin was incorporated into TA 
substrates using the amber suppression system described in (Saraogi et al., 
2011b). A TAG codon was introduced four residues upstream of the TMD. 
Coupled in vitro transcription-translation was carried out as described (Saraogi 
et al., 2011b) in the absence of anti-ssrA oligonucleotide and in the presence of 
2 µM recombinantly purified Sgt2, untagged T7, and untagged CmRS. A 5 mL 
translation reaction was supplemented with 20 mM imidazole (pH 7.5) and batch 
bound to 0.8 mL NiNTA agarose (Qiagen), and washed with 20 CV of GET Buffer 
supplemented to a 300 mM KOAc final concentration and 5mM β-ME as the 
sole reducing agent. Sgt2•TA complex was eluted using GET buffer 
supplemented with 300 mM imidazole (pH 7.5) and 5mM β-ME as the sole 
reducing agent. Elutions (10 mL) were concentrated through 10K concentrators 
(Amicon) and stored at –80 ºC.  The presence of His6-Sgt2 and Strep3-TA was 
verified by Western blotting.  The amount of Sgt2 in the purified complex was 
quantified by Western blotting and standardized against known amounts of 
independently purified His6-Sgt2.   
Purification of Get3BDP•TACm.  Get3BDP•TACm complexes were generated by 
translating TAG-containing TA constructs in the presence of 500 nM Get3BDP.  
Bos1, 2AG, 3AG, 4AG, 5AG, and Bos1-FisC were synthesized from a 5-10 mL in 
the presence of 500 nM Get3BDP.  Translation reactions were loaded onto a 1 mL 
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Strep-Tactin Sepharose (IBA Germany) column and washed with 20 CV of GET 
Buffer. Get3BDP •TA complex was eluted using GET buffer supplemented with 2 
mg/mL desthiobiotin.  Elutions (10 mL) were concentrated through 10K 
concentrators (Amicon) and stored at –80 ºC.  For 6AG, 500 nM Get3BDP was 
supplemented in buffers used during washing and elution. 
 
Translocation reactions.  To assay overall TA translocation, substrates of 
interest were translated for 1 hr in ∆get3 lysate with or without recombinant 
Get3 present (as indicated in the text). Cyclohexamide and ∆get3-derived 
microsomes were then added to initiate translocation.  Substrates were allowed 
to translocate for an hour unless translocation time courses were followed. 
Reactions were quenched by flash freezing in liquid nitrogen following by boiling 
in SDS buffer and analyzed by SDS-PAGE and autoradiography. The 
dependence of translocation efficiency on Get3 concentration for Bos1, 2AG, 
4AG and Bos1-FisC were fit to Eq 3.1,  
 𝑇!"#$ = 𝑇!"#× [!"#!]![!"#!]!!!!/!!  ,    (3.1) 
in which Tobsd is the observed translocation efficiency (%glycosylated TA) at a 
particular Get3 concentration, Tmax is the translocation efficiency at saturating 
Get3, Kd is the Get3 concentration required for half maximal translocation, and h 
is the hill coefficient. The dependence of translocation efficiency on Get3 
concentration for 6AG, Fis1-BosC and Fis1-FisC were fit to a horizontal line. All 
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curve-fitting was conducted using GraphPad Prism 6 for MacOS, GraphPad 
Software, San Diego California USA, www.graphpad.com.  
 
Substrate capture by Sgt2. 100 µL S30 translations were carried out for TA 
substrates of interest in the presence of 35S-methionine and 2 µM His6-tagged 
Sgt2 at 30 ºC for 1 hour. Reactions were adjusted to 50 mM KHEPES, pH 7.5, 
150 mM KOAc, 5 mM Mg(OAc)2,10% Glycerol, 5 mM β-ME, 20 mM Imidazole 
(capture buffer), and incubated (with rotation) with 50 µL Ni-NTA agarose 
equilibrated in capture buffer at 4 ºC for 1 hour.  The mixture was loaded into a 
Mini Bio-Spin Column (Bio-Rad). The resin was washed with 2 mL of capture 
buffer and eluted with 300 µL capture buffer containing 300 mM imidazole. The 
load, flowthrough, and elution fractions were analyzed by SDS-PAGE and 
autoradiography.  Images were quantified using ImageQuantTL (GE Healthcare).  
All capture efficiencies were normalized against that of the internal control (Ctrl 
or Ctrl+3xStrep) translated and captured in parallel with the substrate of 
interest). 
 
Fluorescence measurements of TA transfer. Equilibrium titrations of TA 
transfer between Sgt2 and Get3 were carried out in GET buffer at 25 °C in the 
presence of 20–50 nM Sgt2•TACm complex, 150 nM Sgt2, 150 nM Get4/5, 2 mM 
ATP, and varying concentrations of Get3BDP in a Fluorolog-3-22 
spectrofluorometer (Jobin Yvon). FRET efficiency (E) was calculated according 
to Eq 3.2,  
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 𝐸 = 1− !!"!!  ,     (3.2) 
in which FDA is the fluorescence in the presence of donor and acceptor, and FD is 
the fluorescence of donor in the absence of acceptor. 
The Get3 concentration dependence of the transfer reaction was fit to Eq 
3.3, 
 𝐸!"#$ = 𝐸!"#×    [!"#!]!!/!![!"#!]        ,   (3.3) 
in which Eobsd is the observed FRET efficiency at a given Get3 concentration, 
EMax is the FRET efficiency at saturating Get3 concentrations, and K1/2 is the 
concentration of Get3 required to reach half of the maximal FRET.  
Time courses of TA transfer from Sgt2 to Get3 were measured using a 
stopped-flow apparatus (Kintek). Reactions were initiated by mixing equal 
volumes of ~50nM Sgt2•TACm in 150 nM Sgt2 with a mix of 400nM Get3BDP, 
400nM Get4/5 and 2 mM ATP. For measurements in the presence of lysate, 
∆get3 lysates were spun at 100k rpm in a Beckman TLA 100.1 rotor for 1hr at 4 
ºC to remove ribosomes. These reactions were initiated by mixing equal 
volumes of ~50 nM purified Sgt2•TACm complex (supplemented with 100 nM 
Sgt2) with a mix of 400 nM Get3BDP, 400 nM Get4/5 and 2 mM ATP in ribosome-
depleted lysate. Fluorescence decay of the FRET donor was monitored using a 
445D40M (Chroma) band pass filter. The data were normalized and fit to Eq 3.4,  
 𝐹!"#$ = 𝐹! + ∆𝐹!"#$×𝑒!!!"#$! + ∆𝐹!"#$×𝑒!!!"#$!  , (3.4) 
in which Fe is the fluorescence when the reaction reaches equilibrium, ∆Ffast and 
∆Fslow are the amplitudes of the fluorescence changes in the fast and slow 
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phases, respectively, and kfast and kslow are the rate constants of the fast and 
slow phases, respectively.   
 
Translocation of the Get3•TA complex.  100 µL S30 translations were carried 
out for TA substrates of interest in the presence of untagged Sgt2.  After 
translation, the reactions were supplemented with 2 mM ATP, 2 µM Get4/5 and 
2 µM Get3 to allow TA transfer to Get3 for 1 hour.  Sample was diluted with 2X 
capture buffer and purified as for Sgt2•TA capture. Elutions were concentrated 
to ~50 µL and TA concentration wasmeasured by scintillation counting. Samples 
were normalized to the same number of counts using GET buffer supplemented 
with 20 mg/mL BSA and 5 mM ATP.  
 100 µL targeting and translocation reactions were initiated by adding 20 
µL of ∆get3 microsomes. At various time points, 10 µL samples were removed 
from the reaction and quenched by addition of 2XSDS buffer and flash freezing 
in liquid nitrogen. Samples were analyzed by SDS-PAGE and autoradiography. 
The time course of translocation was fit to Eq 3.5, 
  %𝑡𝑟𝑎𝑛𝑠𝑙𝑜𝑐𝑎𝑡𝑖𝑜𝑛 = 𝑇 + (𝐴 − 𝑇)𝑒!!!"#$! ,   (3.5) 
in which T is the %translocation at the end of the reaction, A is the translocation 
at t = 0, and kobsd is the apparent rate constant of the translocation reaction.  
 In a given translocation reaction, the observed rate constant (kobsd) and 
endpoint (T) of the reaction are contributed by the rate constants of productive 
insertion (kinsert) and nonproductive reactions (knonproductive) according to Eqs 3.6-7,  
  𝑘!"#$ = 𝑘!"#$%& + 𝑘!"!#$"%&'()*+ ,    (3.6) 
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  𝑘!"#$%& = 𝑘!"#$× !!""  .     (3.7) 
The values of kinsert and knonproductive were obtained by solving Eqs 3.6-7.  
 
Kinetic stability of the Get3TA complex.  Dissociation rate constants of 
Get3•A complexes were measured by chasing 20–50 nM preformed 
Get3BDP•TACm complexes with a 10-fold excess of unlabeled Get3.  The time 
course of loss of FRET was monitored and fit to Eq 3.8, 
  𝐹 = 𝐹! + (𝐴 − 𝐹!)𝑒!!!"#$!     (3.8) 
in which F is the observed donor fluorescence at a particular time, Fe is the 
donor fluorescence when the reaction is complete, and kobsd is the dissociation 
rate constant for the Get3•TA complex. 
 
.   
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Figures 
 
 
 
Figure 3.1 
 List and hydrophobicity analysis of the TMDs of ER (A) and mitochondrial (B) 
TAs, as well as the model substrates used in this study (Burri and Lithgow, 
2004; Kalbfleisch et al., 2007) (C). Grand average of hydropathy (GRAVY) scores 
are color ramped for each substrate as indicated by the scale bar. For (B), 
human mitochondrial TAs are highlighted in blue. Abbreviations: PM, plasma 
membrane; NE, nuclear envelope. 
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Figure 3.2 
TAs are targeted to the ER based on TMD hydrophobicity and C-terminal basic 
residues. (A) Nomenclature and schematic of the model substrates used in this 
work.  The sequences of the TMD and CTE are indicated below. (B) Overall 
targeting and translocation of model TA substrates into ER microsomes. TAs are 
translated in a ∆get3 yeast lysate and presented to ∆get3 microsomes in the 
presence of indicated concentrations of purified Get3. (C-E) Quantification of 
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the translocation of TAs for TMD variants (C), CTE variants with Bos1 TMD (D), 
and CTE variants with Fis1 TMD (E). The data for Bos1, 2AG, 3AG, 4AG, 5AG, 
Bos1-FisC, Bos1-RR, and Bos1-RRRR were fit to Eq. 3.1, and the results are 
summarized in Table 3.1. The data for 6AG, Fis1-BosC, Fis1-FisC, Fis1-RR, and 
Fis1-RRRR were fit to horizontal lines with y =10 ± 0.5, y = 25 ± 0.6, y = 9 ± 0.5, 
y = 31 ± 0.7, and y = 5 ± 0.2 %, respectively.  Values are reported as mean ± 
S.E.M, with n = 3-6.  
 
Figure 3.3 
Sgt2 discriminates TAs on the basis of TMD hydrophobicity. (A) Schematic of 
Sgt2•TA capture assay. As an internal control, all TAs were translated and pulled 
down in parallel with Bos1 (Ctrl+3xStrep) or Bos1 lacking the N-terminal 3xStrep 
tag (Ctrl). (B) Autoradiogram of Sgt2TA pulldowns. I, F, and E denote input, 
flowthrough, and elution, respectively. (C) Quantification of the experiments in 
(B). All the quantifications for the TA of interest were normalized against Ctrl or 
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Bos1 Ctrl. Normalized TA capture efficiencies were 0.93 ± 0.04, 0.92 ± 0.08, 
0.56±0.08, 0.53±0.09, 0.44 ± 0.07, 0, 0.413±0.002 and 0.92±0.04 for Bos1, 
2AG, 3AG, 4AG, 5AG, 6AG, Fis1-FisC, and Bos1-FisC, respectively. Values are 
reported as mean ± S.E.M, with n = 3-7  
 
Figure 3.4 
 A fluorescence assay to monitor TA transfer from Sgt2 to Get3. (A) Scheme 
of TA labeling with the non-natural amino acid Cm using amber suppression 
technology in E. coli lysate.  (B) Assessment of amber suppression efficiency. 
Bos1 was translated in the presence of 35S-methionine without (lane 2) or with 
(lane 3-4) an amber codon four residues before the TMD. Lane 4 shows the 
suppression reaction in the presence of CmRS and Cm.  (C) Coomassie stained 
SDS PAGE gel of a purified Sgt2•TACm complex.  (D) Western blot analysis of 
  1     2     3    4
   -     +    +    +   
   -     -     +    +   
   -     -     -     +   
CUA
Cm
UAG
TA
3xStrep
UAG
CmRS
A B
Lane
Amber Codon   
Plasmid
Cm+CmRS
Bos1
Bos1 
truncated
Amber suppression for 
TA labeling
Sgt2
40 kDa
25 kDa
anti His3xStrep
Purified Sgt2•TACm
C
D
anti Strep
Purified Sgt2•TACm
Coomassie
Western Blot
6xHis
6xHis
40 
15 
55 
Ma
rke
r
Sg
t2•
TA
Cm
35 
10 
25 
 kDa
F
 2   15  30  60   90  120  180 2   15  30  60   90  120  180t (min)
WT Get3
ybbR Get3 
SFP
45 kD
WT Get3
ybbR Get3
SFP
CoA-Bodipy-FL labeling of 
ybbR tagged Get3 by SFP
   –          –         +            +yRM
Get3    –          +        WT       ybbR
TA translocation by labeled Get3
   1        2        3         4Lane
IH
0.0
0.5
1.0
k o
bs
d
 (m
in
-1
)
ATPase activity 
Get3 ± Get4/5
G2
0  
 ybbR-Get3
ybbR-Get3BDP
SFP
un
lab
ele
d
+S
FP
 + 
Dy
e
F/T
 - N
iNT
AG
 ybbR-Get3
ybbR-Get3BDP
SFP
35 kD
25 kD
45 kD
35 kD
25 kD
E
TA
Glc-TA WT Get3
+ Get4/5
ybbR
Get3
ybbR
Get3
+Get4/5
WT
Get3
 95 
purified Sgt2•TACm complex.  Sgt2 was His6 tagged and TA was strep3-tagged.  
(E) Location of the ybbR tag (for labeling) on the structure of Get3 (PDB: 3H84).  
(F) Coomassie-stain (top) and in-gel fluorescence (bottom) of Sfp-mediated 
conjugation of CoA-BODIPY-FL to the Get3 ybbR tag.  (G) Labeling and 
purification of labeled Get3. Top, coomassie-stains; bottom, in-gel fluorescence.  
(H) ATPase assay of labeled ybbR tagged Get3.  (I) Translocation assay of 
labeled ybbR tagged Get3. Values are reported as mean ± S.E.M., with n = 3.  
 96 
 
Figure 3.5 
Equilibrium and kinetics of TA transfer from Sgt2 to Get3. (A) Scheme 
depicting the FRET assay for TA transfer from Sgt2 to Get3. Purified Sgt2•TACm 
complex is presented to Get3BDP•Get4/5 complex in the presence of ATP. 
Loading of TACm onto Get3BDP results in gain of FRET between the dye pair. (B) 
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Characteristic fluorescence emission spectra for purified Sgt2TACm complex 
(purple; donor fluorescence), Sgt2•TACm incubated with unlabeled Get3, Get4/5 
and ATP (blue; donor fluorescence corrected for environmental sensitivity), 
Get3BDP and Get4/5 (acceptor fluorescence), and Sgt2TACm complex incubated 
with Get3BDP, Get4/5 and ATP (donor fluorescence in the presence of acceptor). 
(C) Dependence of the equilibrium of TA transfer reactions on Get3 
concentration.  All reactions used ~50 nM Sgt2•TACm complexes supplemented 
with 150 nM Sgt2, 150 nM Get4/5, 2 mM ATP, and indicated concentrations of 
Get3BDP.  The data were fit to Eq 3.3, and the values are reported in (D) and 
Table 3.2. (D) Summary of the Get3 concentrations required for 50% complete 
TA transfer (K1/2 values), derived from the data in (C). Values are reported as 
mean ± S.E.M., with n = 3. (E) Time course of Bos1 transfer from Sgt2 to Get3, 
measured using a Kintek stopped flow apparatus with (black) and without 
Get4/5 (gray), and Fis1-FisC transfer with Get4/5 (green). The data were fit (red 
line) to Eq 3.4, and the derived values are summarized in parts F-G and Table 
3.2. (F, G) Summary of observed rate constants  (part F) and relative amplitudes 
(part G) of the TA transfer reaction for various substrates. Values are reported as 
mean ± S.E.M., with n = 5. (H) TA transfer of Bos1 from Sgt2 to Get3 in the 
presence (blue) and absence (black) of a ribosome depleted yeast lysate. The 
time courses were fit to Eq 3.4 and gave kfast and kslow values of 0.05 ± 0.001 s-1 
and 0.006 ± 0.0002 s-1, respectively, for the reaction in the presence of lysate.  
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Figure 3.6  
Targeting and insertion of the Get3•TA complex into the ER membrane is 
limited by basic residues in the CTE. (A) Schematic of the TA targeting and 
insertion reaction reported in Figure 3.6. Get3•TA complexes generated and 
purified from E. coli lysate were presented to ∆get3 microsomes. Insertion was 
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monitored by glycosylation of the opsin tag on TA substrates in the ER lumen. 
(B-C) Autoradiogram of insertion reactions carried out in parallel. Different 
microsome preparations gave different insertion efficiencies for Bos1 in (B) and 
(C), but did not affect the comparison of the substrates of interest with Bos1 
assayed in the same experiment. (D-E) Quantification of the insertion reactions 
shown in B and C, respectively.  The data were fit to Eq 3.5. (F) Schematic of the 
molecular events during the insertion reaction.  Productive TA insertion (kinsert) 
must compete with nonproductive processes (collectively termed knonproductive), 
including reversal of the targeting reaction, disassembly of the Get3•TA complex 
(kdis) and aggregation of TA substrates (kagg). (G-H) Summary of the rate 
constants of competing events, defined by part F and Eq 3.6-7, that contribute 
to the observed rate constants and efficiencies of the targeting/insertion 
reactions in part C. The rate constants in G and H were derived from the data in 
Figure 3.6D and E, respectively (see also Table 3.3).  (I) The kinetic stability of 
Get3•TA complexes (kdis defined in part D) measured by pulse-chase 
experiments as described under Experimental Procedures. The data were fit to 
Eq 3.8 and dissociation rate constants are summarized in Table 3.3.  
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Figure 3.7  
Effect of Sgt2 depletion on the targeting and insertion of Bos1 and 5AG. (A) 
Western blot of undepleted and depleted ∆get3/SGT2FLAG lysate. (B) 
Autoradiogram of Bos1 and 4AG translocation into ER microsomes in ∆get3 
lysate mock depleted with FLAG resin (top) and ∆get3/SGT2FLAG lysate 
depleted with FLAG resin to remove Sgt2.  Reactions were carried out in the 
presence of 1 µM Get3. (C-D) Quantitation of the results in (B) for mock depleted 
(part C) and Sgt2-depleted lysate (part D). The data were fit to Eq. 3.5, and the 
results are summarized in Table 3.4. 
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Figure 3.8 
Mitochondrial selection for TA protein targeting is imparted by the net 
charge of its C-terminal element.  Nomenclature and schematic of the 
constructs used for live-cell imaging of cells expressing GFP-tagged Fis1 tail 
constructs are shown on the left. Medial focal planes are shown on the right, 
with ER marked by Sec63-tdTomato and mitochondria by mitochondrially 
targeted TagBFP.  Quantification denotes % of cells in each category (mixed 
Mito/ER or Mito only). 
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Figure 3.9  
(A) Model of sequential TA selection by the GET pathway.  Step 1: TAs are 
captured by Sgt2. TA substrates with less hydrophobic TMDs (red coil) are 
rejected.  Step 2: Get4/5 mediated TA transfer from Sgt2 to ATP-bound Get3. 
Substrates with reduced helical propensity are rejected.  Step 3: after 
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hydrolyzing ATP and dissociating from Get4/5, the Get3TA complex associates 
with the membrane receptors Get1 and Get2 that mediate TA insertion. TAs 
enriched in basic residues at the extreme C-termini (red tail) are rejected at this 
step.  (B-C) Free energy profiles for TA capture and insertion without (B) and 
with (C) Sgt2 in the GET pathway.  The free energy profiles for a good substrate 
(Bos1) are indicated in black, for a borderline hydrophobic substrate (5AG) are in 
maroon, for a substrate with reduced helical propensity in the TMD are in green, 
and that for a substrate with a charged CTE (Bos1-FisC) are in blue. Reaction 
schemes for each pathway are represented above the respective free energy 
profile.  
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Table 3.1:  Summary of kinetic parameters for TA targeting and 
translocation ∆get3 lysate. Related to Figure 3.2. 
Substrate K1/2 (µM) Hill Coefficient Tmax (%) 
Bos1 0.18 ± 0.03 1.5 ± 0.3 29 ± 2.3 
2AG 0.11 ± 0.02 1.6 ± 0.4 28 ± 1.8 
3AG 0.42 ± 0.06 1.5 ± 0.2 26 ± 1.5 
4AG 0.57 ± 0.06 1.6 ± 0.2 28 ± 1.6 
5AG 0.76 ± 0.16 1.8 ± 0.4 23 ± 1.8 
Bos1-FisC 0.15 ± 0.06 1.6 ± 0.8 12 ± 2 
Bos-RR 0.19 ± 0.04 2.1 ± 0.8 15 ± 1.4 
Bos-RRRR 0.24 ± 0.07 1.5 ± 0.5 8 ± 1.1 
 
Table 3.2:  Summary of kinetic parameters for TA transfer. Related to 
Figure 3.5. 
Substrate K1/2 
(nM) 
FRET 
endpoint 
kfast (s-1) Fractionfast kslow (s-1) Fractionslow 
Bos1 
(No Get4/5) 
N.D. N.D. 0.0094 
± 7x10-
5 
0.76 
± 0.03 
0.0030 
± 1x10-
4 
0.24 
± 0.03 
Bos1 5.6 ± 1 0.84 ± 
0.03 
0.047 
± 4x10-
4 
0.75 
± 0.007 
0.011 
± 4x10-
4 
0.25 
± 0.007 
2AG 6.4 ± 
0.5 
0.94 ± 
0.02 
0.077 
± 1x10-
3 
0.62 
± 0.005 
0.007 
± 1x10-
4 
0.38 
± 0.005 
3AG 3.7 ± 
0.5 
0.80 ± 
0.01 
0.164 
± 2x10-
3 
0.77 
± 0.002 
0.017 
± 8x10-
4 
0.23 
± 0.002 
4AG 5.7 ± 
0.6 
0.84 ± 
0.02 
0.183 
±9x10-3 
0.54 
± 0.011 
0.033 
± 2x10-
3 
0.46 
± 0.011 
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5AG 10 ± 1 0.80 ± 
0.02 
0.151 
± 9x10-
3 
0.43 
± 0.006 
0.023 
± 8x10-
4 
0.57 
± 0.006 
Bos1FisC 9.3 ± 
0.6 
0.93 ± 
0.02 
0.063 
± 3x10-
4 
0.83 
± 0.002 
0.009 
± 1x10-
4 
0.17 
± 0.002 
 
Table 3.3: Summary of translocation rate constants. Related to Figure 3.6. 
Substrate kobsd (min-1) 
Translocation 
endpoint (%) 
kinsert 
(min-1) 
knonproductive 
(min-1) 
kdis 
(min-1) 
Bos1 0.18 ±0.02 81.2 ± 0.5 0.14±0.01 0.033±0.004 1.8x10
-2  
± 3.4x10-5 
2AG 0.16±0.0003 80.8 ± 0.2 0.126 ± 0.001 
0.030 ± 
0.0002 
2.3x10-2  
± 5.2 x 10-5 
4AG 0.273 ± 
0.0003 74 ± 2 
0.20 ± 
0.006 
0.072 ± 
0.006 
1.7x10-2  
± 6.3x10-5 
6AG 0.7 ± 0.2 36 ± 4 0.3 ± 0.1 0.4 ± 0.1 2.0x10
-1  
± 2.5x10-3 
Bos1-
FisC 0.59 ± 0.007 58.4 ± 4.6 
0.38 ± 
0.004 0.02 ± 0.003 
2.9x10-2   
± 3.0x10-5 
Bos1 0.085 ± 
0.008 53.8 ± 2.1 
0.045 ± 
0.002 
0.039 ± 
0.005  
3AG 0.11 ± 0.008 46.7 ± 2.4 0.053 ± 0.001 0.06 ± 0.008 
2.6x10-2   
± 6.3x10-5 
5AG 0.14 ± 0.4 41.9 ± 2.3 0.06 ± 0.01 0.08 ± 0.03 
3.4x10-2   
± 1x10-4 
Bos1-RR 0.04 ± 0.002 54.8 ±2.1 0.0221 ± 0.0001 
0.018 ± 
0.002 
Not 
determined 
Bos1-
RRRR 0.04 ± 0.004 30.1 ± 1.7 
0.011 ± 
0.0006 
0.025 ± 
0.003 
Not 
determined 
** Values are reported as mean ± S.E.M., with n=2. 
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Table 3.4:  Summary of rate constants of TA translocation without 
preincubation with Get3. Related to Figure 3.7. 
 TA Endpoint k1 (min-1) 
∆get3 
Mock depleted 
Bos1 35.5 ± 1.8 0.053 ± 0.007 
5AG 14.1 ± 0.6 0.057 ± 0.006 
∆get3/SGT2FLAG 
FLAG depleted 
Bos1 26.1 ± 2.2 0.076 ± 0.017 
5AG 15.1 ± 1.0 0.075 ± 0.013 
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